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4Summary
B-aggressive lymphoma 1 protein (BAL1/ARTD9) was described as prognostic marker for the
progression of diৰuse large B-cell lymphoma, the most common lymphoid cancer in humans.
As a macroARTD, BAL1/ARTD9 contains 2 macro and an ADP-ribosyltransferase domain, the
signature of diphteria toxin-like ADP-ribosyltransferases (ARTDs). e aim of this study was to
identify and functionally characterize interaction partners of themacroARTD proteins. Using an
unbiased glutathione S-transferase (GST) pull-down and co-immunoprecipitation approach, full
length and macro domain speciৱc interaction partners of BAL complexes were investigated un-
der physiological conditions. Subsequently, protein interaction partners were identiৱed by mass
spectrometry and validated by western blot. Among other proteins, p62, a signaling hub involved
in selective autophagy, was found as speciৱc interaction partner of the ARTD9 macro domains.
p62 is up-regulated in several human tumors. erefore the eৰect of autophagy induction on
ARTD9 was investigated. We discovered that ARTD9 levels are decreased upon induction of au-
tophagy by starvation in A549 cells. is eৰect was abolished by p62 but not beclin-1 siRNA.
ese results revealed that ARTD9 is degraded by p62 dependent but beclin-1 independent selec-
tive autophagy.
5Zusammenfassung
Das B-aggressive Lymphomprotein (BAL1/ARTD9) wurde als prognostischen Marker ür den
Verlauf von diৰus grosszelligem B-Zell Lymphom identiৱziert, dem meistdiagnostizierten Lym-
phom bei Erwachsenen. Als macroARTD enthält ARTD9 zwei macro Domänen und eine ADP-
ribosyl-transferasen-Domäne, und gehört somit zu den diphterietoxin-ähnlichen ADP-ribosyl-
transferasen (ARTDs). Ziel dieser Arbeit war es, Interaktionspartner von macroARTD Proteinen
zu identiৱzieren und funktionell zu charakterisieren. Unter Verwendung eines unvoreingenom-
menen Immunpräzipitationsverfahrens und mit Hilfe von Glutathion S-Transferase (GST) Pull-
downs wurden Interaktionspartner der gesamtprotein- als auch dermacro-Domänen-speziৱschen
BAL-Komplexe unter physiologischen Bedingungen untersucht. Anschliessend wurden inter-
agierende Proteine mit Massenspektrometrie identiৱziert und miels Westernblot validiert. Das
Protein p62, das an der selektiven Autophagie zentral beteiligt ist, wurde als speziৱscher Interak-
tionspartner der ARTD9 macro Domänen gefunden. p62 ist in mehreren menschlichen Tumoren
hochreguliert. Daher wurde der Eৰekt induzierter Autophagie auf ARTD9 untersucht. Wir stell-
ten fest, dass die Menge an ARTD9 abnimmt, wenn Autophagie durch Hungern in A549 Zellen
ausgelöst wird. Dieser Eৰekt konnte mit p62 siRNA aufgehoben werden, jedoch nicht mit beclin-1
siRNA. Diese Resultate zeigen, dass ARTD9 durch p62 abhängige aber beclin-1 unabhängige se-
lektive Autophagie abgebaut wird.
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91 Introduction
Protection of a host against pathogens and tumor cells is crucial for its survival. e vertebrate
immune system achieves this with three layers: 1. a mechanical/physical barrier working con-
tinuously, 2. innate immunity that reacts within hours and 3. adaptive immunity to target in-
vaders speciৱcally within several days. To avoid invading pathogens, i.e. infectious diseases, the
immune system reacts rapidly and tightly coordinated. Overreaction of in৲ammation and immu-
nity can harm the host, therefore homeostasis between activation and suppression of the defense
mechanisms is key for survival (1). Aberrant signaling oen leads to chronic in৲ammatory dis-
orders and cancer (2). Post-translational modiৱcations (PTMs) are a fast, accurate and reversible
way to regulate signaling and transcription. ese modiৱcations include phosphorylation, acety-
lation, methylation, ubiquitination and adenosine diphosphate ribosylation (ADP-ribosylation)
(3–5). Another key regulator of in৲ammation and immunity proteins is the autophagy signaling
pathway (6–9).
1.1 The family of intracellular diphteria toxin-like mono- and
polymerizing-ADP-ribosyltransferases
ADP-ribosylation is the enzymatic transfer of the ADP-ribose moiety from nicotinamide adenine
dinucleotide (NAD+) onto acceptor amino acid side chains and/or ADP-ribose units bound to tar-
get proteins. A schematic representation of the mono-ADP-ribosylation process of an asparagine
is shown in Fig. 1.
Figure 1. Mono-ADP-ribosylation of a protein at an asparagine residue. From (10)
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ADP-ribosylation is mediated by mono- and poly-ADP-ribosyltransferases (11). ese enzymes
contain an active site with similarities to diphtheria toxin and are therefore known as diphtheria
toxin-like ADP-ribosyltransferases (ARTDs) (12). In humans, 17 members of the ARTD family
have been found, all of which contain an ADP-ribosyltransferase (ADPRT) domain also referred
to as catalytic domain (12, 13). ree family members, ARTD7/B aggressive lymphoma protein 3
(BAL3), ARTD8/BAL2 and ARTD9/BAL1, contain multiple N-terminalmacro domains (14). ese
three proteins, termed macroARTDs, are conserved in many eukaryotic species, with the excep-
tion of rodents, which lack ARTD7. emacroARTD genes are located on the human chromosome
3q21 and form a cluster (15). ARTD8 and ARTD9 are expressed during mouse development and
adulthood prominently in the thymus (16). e macroARTDs ARTD7 and ARTD8 were shown
to be mono-ADP-ribosyltransferases. e ADPRT domain of ARTD9 is probably inactive, due
to amino acid substitutions in the histidine, tyrosine and glutamate (HYE) triad of the catalytic
domain. Instead, it contains the motif glutamine, tyrosine and threonine (QYT) (14, 17, 18).
Another domain present in ARTD8 is the WWE domain (named aer the conserved tryptophans
and a glutamic acid), predicted to be a protein-protein interaction module necessary for targeted
ubiquitination and ADP-ribosylation (19). Recently, this domain was reported to bind iso-ADP-
ribose and poly(ADP-ribose) polymer (PAR) (20). A schematic representation of the domain struc-
ture of ARTD7–9/BAL1–3 and the respective macro domains expressed during this study as His-
GST fusions is shown in Fig. 2.
Figure 2. Schematic representation of human ARTD7–9/BAL1–3 proteins and the recombi-
nantly expressedmacro domains. e amino acids at the positions of the HYE triad of ARTD1
are indicated below the catalytic domains.
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1.1.1 Macro domains are ADP-ribose-binding protein modules
Using a multiple sequence alignment (MSA), A. E. Gorbalenya, E. V. Koonin and M. M.-C. Lai
discovered that the domain with the highest similarity in α- and rubivirus is also conserved in
coronaviruses and denoted it X domain (21, 22). Shortly aer, J. R. Pehrson and V. A. Fried isolated
and cloned the histone variant macroH2A that is almost three times as large as canonical histone
H2A. MacroH2A is associated with transcriptional repression and X chromosome inactivation
(23). It contains a carboxy-terminal non-histone segment, termed macro domain (24). Alignment
of these domains suggested that they constitute the same family. erefore, themacro or X domain
is a phylogenetically ancient and highly conserved protein module found in proteins of several
eukaryotic and prokaryotic species as well as in positive-stranded RNA viruses. Several macro
domains were shown to bind the NAD+ metabolites poly(ADP-ribose) polymer (PAR) , monomeric
ADP-ribose (ADPr) and the sirtuin metabolite O-acetyl-ADP-ribose (OAADPr).
Additionally, several mammalian and bacterial macro domain proteins had phosphatase activity
and were able to hydrolyze ADPr-1”-phosphate, a by-product of tRNA splicing (25–30).
Viralmacro domains are found in all viruses of theCoronaviridae family, in Rubella viruses, Alpha
viruses and Hepatitis E virus (22, 31). Viral macro domains were shown to bind to bind PAR as
well as poly(A) (29, 32). e bacterial macro domain-only protein AF1521 was shown to bind the
NAD+ metabolites PAR, ADPr and OAADPr (33).
MacroH2A has been associated with the inactive X chromosome in female mammals and is im-
plicated in transcriptional regulation in vertebrates. In mammals, macroH2A2 and two splicing
variants of macroH2A1 exist (34). Of the three mammalian macroH2A isoforms macroH2A1.1,
macroH2A1.2 and macroH2A2, only macroH2A1.1 is able to bind PAR, ADPr and the sirtuin
metabolite OAADPr (35). In contrast, the human macroD2, was found to reside in both nucleus
and cytoplasm, possibly shuling, and binding speciৱcally to monomeric ADPr with high a৳n-
ity (Kd = 0.15 µM). However, it did not bind PAR e৳ciently (29). Since endogenous ARTD1 is
poly- and mono-ADP-ribosylated as well (36, 37), severalmacro domain containing proteins bind
ARTD1, for example AF1521, ALC1 and mH2A1.1 (33, 35, 36, 38).
MacroARTDs are so far the only proteins characterized, that contain multiple macro domains.
e macro domains of ARTD7, ARTD8 and ARTD9 are conserved, but contrary to expectations,
the intermolecular similarities are higher than the intramolecular evolutionary conservation (14).
e evolutionary tree of the macro domains of ARTD7, ARTD8 and ARTD9 is shown in Fig. 3.
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Figure 3. e evolutionary tree of the human macro domains. PAR14 indicates ARTD8,
PAR15 ARTD7 and PAR9 ARTD9. e intermolecular similarity between the macro domains
of ARTD7–ARTD9 is higher then the intramolecular similarity. Personal communication, M.
Hassler (EMBL, Heidelberg).
1.1.2 General roles of ARTD9/BAL1 and ARTD8/BAL2 in immunity and
tumorigenesis
ARTD9/B-aggressive lymphoma 1 (BAL1) has been discovered in a genome-wide screen as can-
didate gene, whose expression correlates with risk and chemoresistance in diৰuse large B-cell
lymphoma (DLBCL) (15). In a recent microarray study, ARTD9 was shown to be signiৱcantly
upregulated upon signal transducer and activator of transcription 6 (STAT6) knockdown (STAT6
acts downstream of interleukin 4 (IL-4), cf. section 1.2 below) by short hairpin RNA (shRNA) in
a classical Hodgkin lymphoma cell line (39). BAL2/ARTD8, another member of the same fam-
ily, is suggested to be a transcriptional activator/switch for STAT6 (40, 41). It was shown to
protect against apoptosis in IL-4 treated cells (42) IL-4 inhibits 1 response and IFNγ produc-
tion, while IFNγ inhibits 2 response, as mentioned below (section 1.2). erefore the discovery
that ARTD9 and B-lymphoma- and BAL-associated protein (BBAP) are regulated by the same
interferon-responsive bidirectional promoter (43) indicates, that ARTD9 and ARTD8 act in an an-
tagonistic way.
1.1.3 Specific Roles of the ARTD9/BAL1 as modulator of STAT1/IRF1 in
tumorigenesis
In our lab, ARTD9 was found as a co-activator of STAT1 and repressor for tumor suppressor inter-
feron regulatory factor 1 (IRF1) in SUDHL7 DLBCL cells. Meanwhile, it stimulated the expression
of the proto-oncogenes B-cell lymphoma 6 (BCL6), BCL2 and IRF2 in these cells. ARTD9/BAL1
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bound to the IRF1 promoter as well as its own promoter. ARTD9/BAL1 physically interacts with
both STAT1α and STAT1β through its macro domains (44).
1.2 General roles of interferons in innate immunity and
tumorigenesis
Adaptive immunity is mediated by lymphocytes (B- and T-cells) through the production of cy-
tokines. ese small secreted mediators control diৰerentiation, proliferation and apoptosis of
white blood cells (WBCs) and other cells of hematopoetic origin (45, 47). A major trigger of the
immune response is the equilibrium between type 1 T helper CD4+ cells (1) and type 2 T helper
CD4+ cells (2). A hallmark of 1 or inﬂammatory T cells is the production of interferon γ
(IFNγ), which activates macrophages and stimulates an in৲ammatory response. e1 response
is important for defense against intracellular bacteria, viruses and cancerous cells and is neces-
sary for type IV hypersensitivity. Conversely, the cytokine interleukin 4 (IL-4) shis the immune
system towards 2 response, also called humoral immunity. is immune response is responsi-
ble for the production of high a৳nity antibodies against extracellular pathogens. IL-4 promotes
activated B-cells to proliferate and induces activation-induced deaminase, which is required for
class switch recombination to the IgE isotype and somatic hypermutation. Since IL-4 inhibits
1 response and IFNγ production and vice versa, 1 and 2 response act in an antagonistic
way (48).
IFNs and IL-4 elicit their functions through binding to transmembrane receptors. Receptor associ-
ated Janus kinase (JAK) subsequently phosphorylates cytoplasmic signal transducer and activator
of transcription (STAT) on tyrosine residues. Upon IL-4 binding to the IL-4/IL-13 receptor, STAT6
forms dimers, translocates to the nucleus and binds speciৱc DNA sequences to regulate gene
transcription (Fig. 4) (45, 47).
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Figure 4. Schematic representation of the JAK-STAT pathway. Extracellular cytokines, i.e.
IL-4 and IFN’s interact with the transmembrane receptor and initiate an intracellular phos-
phorylation cascademediated by receptor associated Janus kinases (JAK). JAKs phosphorylate
tyrosine residues of cytoplasmic STAT, which dimerizes upon this modiৱcation. STAT homo-
or heterodimers translocate to the nucleus and bind to canonical DNA elements. Nuclear co-
activators induce transcription and chromatin modiৱcations (45). Diagram reproduced from
(46).
In a variation of the same theme, type I interferons, i.e. IFNγ, act as ligands by binding to the
transmembrane receptor. en, JAK1 and JAK2 phosphorylate cytoplasmic STAT1, which forms
homodimers and is rapidly transported to the nucleus where it binds to the conserved DNA ele-
ments with the sequence of 5’-TT(N)4−6AA-3’. In contrast, type II interferons (IFNα and IFNβ)
lead to STAT1/STAT2 heterotrimers with the interferon regulatory factor 9 (IRF9). ese het-
erotrimers, also called interferon-stimulated gene factor 3 (ISGF3), translocate to the nucleus and
bind to the sequence 5’-AGTTT(N)₃TTTCC-3’ (49).
e IFNγ induced IRF1 is an important target gene of STAT1 (50). As transcription factor, IRF1
regulates several gene clusters involved in host defense, cell proliferation and diৰerentiation (51,
52). erefore, IRF1 has an important role in innate immunity supplementary to its function as a
tumor suppressor (53). Another target gene of IFNγ is ARTD9/BAL1 that was shown to be directly
involved in the IFNγ signaling pathway (43).
e next level of complexity is added by the suppressor of cytokine signaling (SOCS) proteins,
that are induced by cytokines (54). SOCS, Nmi, protein inhibitors of activated STATs (PIAS) and
a STAT ubiquitin E3 ligase (SLIM) are negative regulators of the JAK-STAT pathway and act in a
classical negative feedback loop (55–57). Together, they prevent the overreaction of the immune
response.
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1.3 Lymphoma
Originating from normal B-cells, malignant B-cells exploit intrinsic regulation mechanisms as
cytokine signaling to usurp their host (58). ese cancer cells acquire the ability to divide indeৱ-
nitely, through accumulation of mutations in genes that are involved in cell growth and prolifer-
ation and epigenetic alterations (59). eir daughter cells inherit this characteristic to proliferate
unrestrained, form a clone and subsequently a mass called tumor or neoplasm. A benign neo-
plasm remains localized and encased in a ৱbrous capsule; a malign tumor penetrates the basal
lamina and spreads through the vascular system into the whole body. e daughter cells invade
the tissue aer re-aachment to the vascular endothelium, outgrow their environmental cells
and form metastases. Primary neoplasm and metastases can remain asymptomatic or give rise to
disease (1).
1.3.1 Subtypes of Lymphoma
White blood cell (WBC) neoplasms primarily arise from lymphocytes and are generally classiৱed
in leukemia and lymphoma. e former designates a lymphocytic cancer, which originates in
the bone marrow and is generally manifest in the peripheral blood. e laer, in contrary, is
usually of lymph node origin and forms a tumor mass most frequently in the lymph nodules
itself. Dependent on the identiৱcation of Reed-Sternberg cells, the hallmark of Hodgkin disease,
the lymphoma is classiৱed in the two large categories Hodgkin and Non-Hodgkin lymphoma
(NHL) (60). NHL has the highest incidence among lymphoid neoplasms in Switzerland as well as
worldwide (61). Non-Hodgkin’s B-cell lymphomas have characteristics of cancer, immunity and
in৲ammation (62)
e most prevalent subtype of NHL, diৰuse large B-cell lymphoma (DLBCL), accounts for 30–40%
of new lymphoma cases per year (58). e histophathological features of this cancer are are large
cell size and diৰuse growth paern and the cells stain positive for CD20.
DLBCL is considered an aggressive disease in humans (median age 60), although juveniles and
children are aৰected too. If le untreated, this lymphoma is fatal aer a short survival time. It is
usually treatedwith an anthracycline based combination therapy consisting of cyclophosphamide,
doxorubicin (hydroxydaunorubicin), vincristin (oncovin) and prednisone (CHOP) (63). Recent
progress due to the addition of anti-CD20 antibodies (Rituximab®) to CHOP (R-CHOP), led to
remission rates between 60–80% (64). Notwithstanding this achievement, the survival rate stag-
nates, still 40–50% of the patients remain incurable and die of their disease (60).
Interestingly, DLBCL survival time, death risk and prognosis varies considerably among patients,
albeit the histopathological properties are identical. is points to underlying molecular diৰer-
ences in DLBCL responsible for diৰerent outcome. Using molecular proৱling, DLBCL was strat-
iৱed in subgroups, which correlate with overall survival – germinal center B-cell (GCB)-like DL-
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BCL has the longest survival aer chemotherapy, activated B-cell (ABC)-like DLBCL the shortest
(65, 66). Based upon these results, IL-4 was shown to sensitize GCB-like DLBCL to R-CHOP, while
protecting ABC-like DLBCL from R-CHOP cytotoxicity (67). Since IL-4 levels in both GCB and
ABC-like DLBCL are similar (68), this could be a reason for the diৰerent clinical outcomes.
1.4 Regulation of innate immunity and tumorigenesis through
autophagy
Autophagy, from theGreek „αυτoς” oneself and „φαγειν” to eat, denotes a catabolic cellular path-
way that is conserved from yeast to mammals (69). ere is mounting evidence that autophagic
failure plays an important role in the pathogenesis of infectious diseases, cancer, myopathies,
neurodegeneration, bone and metabolic disorders (70).
In cells, there exist two major degradation pathways: autophagy and the proteasome system.
Proteins can be degraded by the 26S proteasome in a highly selective way. In contrast, lipids,
intracellular proteins as well as whole organelles and pathogens can be targeted to the lysosomes
for degradation. Autophagy evolutionarily emerged as a catabolic process to replenish the cell
with nutrients during starvation (72). While diৰerent forms of autophagy have been described in
mammalian cells, among them macroautopagy, microautophagy, piecemeal microautophagy of
the nucleus and chaperone-mediated autophagy (CMA) (71), the following paragraphs will focus
on macroautophagy, thereaer referred to as autophagy.
Autophagy is initiated when the phagophore, a membrane sac originating mainly from the en-
doplasmic reticulum (ER), grows and encloses cytoplasmic material to form the autophagosome
(Fig. 5).
Figure 5. Schematic representation of autophagy. a,b,c. Cytoplasmic content is enveloped by
the phagophore to form the autophagosome, a doubled membrane enclosing cytoplasmic con-
tent. d. e autophagosome fuses to a lysosome to form an autophagolysosome. e. Contents
are then degraded together with the inner membrane. Diagram reproduced from (71).
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ereaer the autophagosome will fuse with a lysosome into an autophagolysosome. e con-
tents of the autophagolysosome are then degraded by the lysosomal hydrolases and the resulting
macromolecules (mostly amino acids) are used for further anabolic processes (71).
Even when nutrients are abundant, hepatocytes degrade 1-1.5% of their proteins per hour by au-
tophagy (73). ite reasonable, autophagosome formation is induced when cells are deprived of
growth factors and nutrients such as amino acids (74–76). IFNγ, a pleiotropic cytokine, has also
been found to induce autophagy in macrophages (77), T lymphocytes (78), mammary epithelial
(79) and HeLa cells (80). In a negative feedback loop, restored amino acid levels re-establish basal
levels of autophagy by activation of the serine/threonine protein kinase mammalian target of ra-
pamycin complex 1 (mTORC1) (81). In this feedback loop, p62, a scaৰold protein implicated in
multiple cellular functions including autophagy, was found to interact with raptor, a component
of the mTORC1 complex. p62 is required for amino acid sensing by mTORC1 (82). e absence
of growth factors also inactivates mTORC1 in a phosphoinositide-3-OH kinase (PI3K) and phos-
phatase and tensin homolog on chromosome ten (PTEN) dependent way (83). mTORC1 is a major
cell growth and proliferation regulator. Not surprising, it’s activity is oen deregulated in human
cancer (84). For example, loss-of-function mutations in the gene of PTEN are detected at a rate
almost as high as observed in tumor suppressor p53 (85, 86).
Downstream, mTORC1 phosphorylates eukaryotic initiation factor 4E-binding protein (4E-BP1)
and 70kDa protein S6 kinase (p70S6K) to control protein synthesis. p70S6K phosphorylation is
therefore oen used as readout for the activity of mTORC1 (83).
1.4.1 Nucleation of the autophagosome
e molecular machinery of autophagy consists of 35 autophagy-related (Atg) genes (88). It was
studied in yeast, but many yeast genes have homologues in higher eukaryotes (89, 90). When nu-
trients are abundant, mTORC1 inhibits the unc-51-like kinase 1 (ULK1)/Atg1 complex consisting
of the proteins ULK1, Atg13, FIP200, and Atg101 (Fig. 6).
18 Introduction
Figure 6. Schematic representation of the macroautophagy pathway. (Copyright © Cell Sig-
naling Technology, Inc.), adapted from (87).
Upon starvation, autophagy is induced by the translocation of the ULK1 complex to the endo-
plasmic reticulum (ER). ere, it interacts with the class III phosphatidylinositol-3-OH kinase
complex (PIK3C3) (beclin 1, Atg14(L)/barkor, Vps15, Vps34, and ambra1) (83) which produces
phosphatidylinositol-3-phosphate (PtdIns(3)P). PtdIns(3)P leads to the recruitment of double FYVE-
containing protein 1 (DFCP1) andWD-repeat domain phosphoinositide-interacting (WIPI) family
proteins to the autophagosome (6).
1.4.2 Elongation of the isolation membrane
Two ubiquitin-like conjugates are essential for the elongation and closure of the autophagosme-
isolationmembrane. First, theAtg7 (E1-like) andAtg10 (E2-like) enzymes conjugateAtg12 (ubiqui-
tin-like) to Atg5. e Atg12–Atg5 conjugate forms thereaer a dimer together with ATG16L1 (91).
Second, the Atg7 (E1-like) and Atg3 (E2-like) enzymes produce phosphatidylethanolamine (PE)-
conjugated Atg8 homologues – Microtubule-associated protein light chain 3 (LC3), GATE16 and
GABARAP – which are present on both sides of the isolation membrane (88, 92). e conversion
of LC3 (LC3-I), which migrates with a molecular mass of 16kDa, to PE-conjugated LC3 (LC3-II),
which runs faster on SDS-PAGE due to hydrophobicity (at approximately 14kDa), can be detected
by western blot (93). At present, LC3-II is the best characterized marker for autophagy (94).
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1.4.3 Selective autophagy
For a long time, (macro-)autophagy was considered a non-speciৱc bulk degradation pathway.
is view is not anymore appropriate, since p62/Sequestosome-1, a cargo receptor for selective
autophagy, has been found (95, 96). p62 acts as platform to target proteins selectively to the au-
tophagosome, together with the proteins neighbor of BRCA1 (NBR1) and nuclear dot protein 52
(NDP52) (69).
In chaperone-mediated autophagy (CMA), another well characterized selective autophagy path-
way in mammalian cells, proteins containing the sequence KFERQ interact with the chaperone
heat shock protein 70 (hsc70) to be degraded by the lysosome (97–100).
p62/Sequestosome-1
e protein p62/Sequestosome-1 is a substrate for selective autophagy but at the same time acts
as adaptor for proteins degraded by selective autophagy. It mediates this function by physical
interaction with all mammalian Atg8 analogs bound to the isolation membrane through its LC3-
interacting region (LIR) (96, 101). When autophagy is inhibited, p62 accumulates and forms in-
clusion bodies together with ubiquitin (102). Such p62 positive protein aggregations have been
identiৱed in Alzheimer and Parkinson disease, amyotrophic lateral sclerosis, hepatitis, malignant
glioma and hepatocellular carcinoma (103). p62-accumulation correlates negatively with the level
of autophagic activity in cells, this is useful to monitor autophagic ৲ux (94).
With its UBA domain, p62 binds to poly- and monoubiquitin in vitro (104–106). Mono-ubiquitiny-
lation has been shown to be su৳cient for substrates to be degraded by selective autophagy (107).
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2 Aim
Despite the crucial, risk-related role of B aggressive lymphoma (BAL) proteins in DLBCL and
their high evolutionary conservation, only few interaction partners of these proteins have been
characterized to date. ese include Signal transducer and activator of transcription (STAT) 6,
p100 (TSN) and phosphoglucose isomerase (PGI)/autocrine motility factor (AMF) as interaction
partners for ARTD8 and BBAP for ARTD9 (40, 108–110). According to own unpublished data
ARTD8 interacts additionally with STAT2 and BBAP and ARTD9 forms complexes with STAT1,
STAT2, IRF9 and BBAP (personal communication, P. O. Hassa). Identiৱcation of new binding
partners could lead to a beer understanding of the physiological role of BAL proteins in cancer
and immunity.
e aim of this project was to investigate and functionally characterize binding partners of both
the full length BAL proteins as well as their respective single and tandem macro domains using
an unbiased approach. Severalmacro domain containing proteins are recruited to sites of nuclear
ARTD1 activation induced by low power laser-generated DNA damage (36, 38, 111). erefore,
we set out to investigate whether the macro domains of BAL proteins interact with ARTD1 and
other proteins.
For this purpose, we expressedHis-GST tagged BALmacro domains in bacteria. Aer puriৱcation,
these macro domains were used as bait in GST pull-downs with extracts of diৰerent mammalian
cell lines. en, the co-puriৱed complexes were separated by SDS-PAGE and visualized using a
silver stain. Subsequently the bands representing probable interaction partners were selected for
identiৱcation bymass spectrometry. In a similar approach, hemagglutinin (HA) tagged full length
ARTD9 protein was stably expressed in A549 cells, to investigate the interaction partners of the
full length BAL proteins. Extracts from these cells were then used for co-immunoprecipitation
experiments.
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3 Materials and Methods
3.1 Solutions
3.1.1 Protein extraction buﬀers
WCE buﬀer
50mM Tris pH 7.5
1% (v/v) NP-40
420mM NaCl
Complete tablets (protease inhibitors) (Roche)
ddH2O
Buﬀer A
50mM Tris pH 7.5
Complete tablets (protease inhibitors) (Roche)
ddH2O
Buﬀer A*
50mM Tris pH 7.5
0.1% (v/v) NP-40
Complete tablets (protease inhibitors) (Roche)
ddH2O
Buﬀer B
50mM Tris pH 7.5
420mM NaCl
1% (v/v) NP-40
Complete tablets (protease inhibitors) (Roche)
ddH2O
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3.1.2 SDS-PAGE and western blot solutions
5 x Running buﬀer
125mM Tris base
1M Glycine
0.5% Na-dodecylsulfate (SDS)
ddH2O to 5 L
Solution B
1.5M Tris pH 8.8
0.4% Na-dodecylsulfate (SDS)
ddH2O
Solution C
0.5M Tris pH 6.8
0.4% Na-dodecylsulfate (SDS)
small amount Bromphenol blue ddH2O
10 x Transfer Buﬀer
25mM Tris-base
192mM Glycine
200mL Methanol
ddH2O to 1 L
Store at 4℃.
10 x TBS
100mM Tris-HCl pH 7.5
1.5M NaCl
ddH2O to 1 L
TBST
100mL 10 x TBS
0.5mL Tween 20
ddH2O to 1 L
10 x PBS
80 g NaCl
2 g KCl
14.4 g Na2HPO4
2.4 g KH2PO4
pH 6.8.
ddH2O to 1 L
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3.1.3 Silverstain solutions
According to a silver stain protocol fromRalph Imhof/Functional Genomics Center Zurich (FGCZ).
Fixing solution
50 % (v/v) EtOH
10% (v/v) Glacial acetic acid
ddH2O
Rinsing solution
50 % (v/v) EtOH
ddH2O
Sensitizer, for 200mL
0.058 g Sodium thiosulphate pentahydrate
ddH2O
Stain, for 200mL
0.2 g Silver nitrate
ddH2O
Store on ice before use
Developer, for 500mL
10 g Sodium carbonate
20mL Sensitizer
200µL Formaldehyde
ddH2O
Stop solution
1 % (v/v) Acetic acid
ddH2O
3.1.4 Bacterial medium
2 x LB medium, per 1 L Prepared according to (112).
Bactotrypton 20 g
Yeast extract 10 g
NaCl 10 g
ddH2O to 1 L,
autoclaved
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10 x PSB medium, per 1 L Prepared according to Paul O. Hassa, personal communication.
Bactotrypton 100 g
Yeast extract 20 g
Casamino acids 20 g
NaCl 50 g
NH4Cl 10 g
KH2PO4 30 g
Na2HPO4 60 g
ddH2O to 1 L
pH adjusted to
7.2, autoclaved.
3.1.5 Antibodies
Anti-phospho-AMPK (r172) Rabbit monoclonal 40H9, Cell Signaling, #2535, used at 1:1000
Anti-AMPKα Cell Signaling, #2532, used at 1:1000
Anti-ARTD1 Immunization done at UZH, used at 1:2000
Anti-ARTD8 Gi from A. Raz (110), used at 1:1000
Anti-ARTD9 Millipore, C-terminal, AB10618, used at 1:250
Anti-ARTD10 Aviva Systems Biology, ARP42810_P050 and ARP42811_P050,
used at 1:1000
Anti-ARTD13 GeneTex, GTX120134, used at 1:20,000
Anti-beclin-1 Santa Cruz Biotechnology, used at 1:1000
Anti-HA Sigma, monoclonal HA-7, used at 1:10,000
Anti-LC3A/B Cell Signaling, #4108, used at 1:1000
Anti-Nucleolin Santa Cruz, sc-8031, used at 1:1000
Anti-Nucleolin GeneTex (for mouse), GTX16940, used at 1:1000
Anti-p62 Epitomics, 3340-1, used at 1:10,000
Anti-p68 Millipore, clone PAb204, used at 1:1000
Anti-phospho-p70S6K (r389) Cell Signaling, #9205, used at 1:1000
Anti-PAR 10H from (113), used at 1:5000
Anti-PAR Becton Dickinson, LP-96-10, used at 1:3000
Anti-Tubulin Sigma, used at 1:10,000
Secondary Antibodies
Anti-rabbit ECL TM anti-rabbit IgG, horseradish peroxidase linked whole
antibody (from donky), NA934V, GE Healthcare UK Limited
Anti-mouse ECL TM anti-mouse IgG, horseradish peroxidase linked whole
antibody (from sheep), NA931V, GE Healthcare UK Limited
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3.2 Bacterial protein expression
3.2.1 Plasmids and sequencing
pETM33 vectors (P. O. Hassa & EMBL core facility) were used for the cloning and expression of
(His)₆-GST tagged single and tandem (duplicated) macro domains. Cloning was performed by
Paul O. Hassa. Sequencing of plasmids was performed by Microsynth (Balgach). Minipreps and
preparation of chemically competent cells were performed according to standard methods (112).
3.2.2 Expression of (His)₆-GST tagged macro domains in bacteria
50µL competent BL21(DE3) pLysS cells (Novagen) were thawed on ice for 10min, transformed
with 5µL plasmid DNA by heatshock at 42℃ for 50 s and incubated again 2min on ice. en, the
E. coli cells were incubated with 400µL Luria Bertani (LB) medium without antibiotics for 1 h at
37℃. e whole suspension was added to 15mL LB medium with 50µg/mL chloramphenicol and
50µg/mL kanamycin and incubated over night at 37℃.
ARTD7, ARTD8 and ARTD9 single and tandem macro domains were expressed in 200mL PSB
medium supplemented with 50µg/mL chloramphenicol and 50µg/mL kanamycin as (His)₆-GST
fusions at 16℃ for 16 h with 200µM IPTG induction. e culture suspension was centrifuged for
20min at 4000 rpm (5299 rc) in a H6000A rotor (Sorvall 3C centrifuge, Fisher Scientiৱc) to harvest
the bacteria. e resulting pellets were resuspended in ice-cold resuspension buৰer (50mM Tris-
HCl, pH 7.5, 500mM NaCl, 10% glycerol, 2mM PMSF) by shaking at 260 rpm, 0℃, snap-frozen in
liquid N₂ and stored at −80℃.
3.2.3 Nickel purification of (His)₆-GST tagged macro domains
Cell suspension was thawed in a cold water bath, supplemented with lysozyme, 1% NP-40 and
2mM PMSF and lysed rotating at 4℃ for 1 h. DNAse I and 10mMMgCl₂ were added to digest nu-
cleic acids and the suspension was rotated for an additional hour at 4℃.e lysate was centrifuged
for 30min at 12000 rpm (17600 rc) in a SS-34 rotor at 4℃ (Sorvall RC 5C PLUS centrifuge, Fisher
Scientiৱc). e supernatant ”crude protein extract” was incubated for 2 h with High Performance
Nickel Sepharose (Amersham Biosciences, Sweden), aer adjustment of the NaCl concentration
to 1M. Beads were washed twice with 15mL of washing buৰer (50mMTris-HCl, pH 7.5, 1MNaCl,
0.5% NP-40 and 2mM PMSF) and once with the same buৰer containing 1.5M NaCl. Elution was
done with elution buৰer containing 50mM Tris-HCl pH 8, 200mM imidazole and 100mM NaCl.
Aer addition of 10% glycerol, the puriৱed proteins were snap-frozen in liquid N2 and stored at
−80℃.
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3.3 Mammalian cell culture
3.3.1 Cell lines and culture conditions
All media were stored at 4℃ and preheated to 37℃ in a warm water bath before use. Mammalian
cells were cultured at 37℃ and 5% CO2, in a humiৱed incubator. Cell culture experiments were
performed under a sterile hood. A modiৱed Neubauer counting chamber was used to determine
the exact cell number.
293T
e Human embryonic kidney cell line (293T) is a derivative of the human primary embryonal
kidney cell line 293 additionally containing the SV-40 large T-antigen. ese cells are easily trans-
fectable by the calcium phosphate method. 293T cells were cultured in Dulbecco’s modiৱed Ea-
gle’s medium (DMEM) substituted with 10% Fetal bovine serum (FBS), 2 nM L-glutamine and
addition of (50 U/mL) penicillin and (50µg/mL) streptomycin. Cells doubled approximately every
24 hours and were split 1:10 when they reached 90% con৲uence (every three days).
RAW-264.7
is line of mouse monocytes/macrophages was originally isolated from a mouse tumor induced
by a Abselon leukaemia virus. Adherent Mouse monocyte/macrophage cell line (RAW-264.7)
macrophageswere grown in RPMI-1640medium supplementedwith 10% FBS and penicillin (50 U/mL)/
streptomycin (50µg/mL). Cells doubled approximately every 24 hours and were split by scraping
1:3 when they reached 90% con৲uence.
A549
e A549 cell line was established in 1972 by D. J. Giard, et al. through the removal and culturing
of cancerous lung tissue in the explanted tumor a of 58-year-old caucausian male. A549 cells are
immortalized human type II bronchial epithelial cells obtained from lung carcinomatous tissue.
e adherent cells were cultured in DMEM substituted with 10% FBS, 2 nM L-glutamine and addi-
tion of (50 U/mL) penicillin and (50µg/mL) streptomycin. Cells doubled approximately every 24
hours and were split 1:10 when they reached 90% con৲uence (every three days). e stable cell
lines A549 empty and A549 HA-ARTD9 were established by co-transfection of A549 cells with
the PiggyBac plasmid containing no insert or the cDNA for HA tagged human ARTD9/BAL1 iso-
form 2 together with a recombinase plasmid with Lipofectamine 2000 (Invitrogen). Cloning of the
PiggyBac plasmids was performed by Paul O. Hassa.
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U-2932
e human B-cell line U-2932 was derived from ascites of a DLBCL patient previously treated
multiple times for Hodgkin lymphoma (114). It is Eppstein-Barr virus negative. e suspension
cells were cultured in RPMI-1640 medium supplemented with 10% FBS and antibiotics (penicillin
100 U/mL/streptomycin 50µg/mL). Cells doubled approximately every 48 hours and were split 1:3
when they reached 90% con৲uence.
3.3.2 Preparation of whole cell extracts (WCE)
Aer aspiration of the supernatant, adherent cells were washed with 10mL PBS and harvested
with 4mL PBS EDTA per 10 cm dish. Suspension cells were directly transferred to a 50mL tube
(TRP) and semi-adherent macrophages (RAW-264.7) and SU-DHL-7 lymphocytes were scraped.
An aliquot of the cell suspension was taken for a subsequent western blot. en, the cell suspen-
sion was centrifuged for 3min at 1000 rpm, the supernatant was aspirated and cell pellets were
frozen and stored at −80℃. Aer thawing, 3 pellet volumes of WCE buৰer were added to the
pellets. Aer pipeing up and down, transfer to an Eppendorf tube and vortexing of the solution,
the solution was rotated for 30min at 4℃. Non soluble cell debris was removed by centrifugation
at 14000 rpm for 30min at 4℃. e remaining supernatant was called whole cell extract (WCE).
3.3.3 Preparation of cytoplasmic and nuclear extracts
Aer aspiration of the supernatant, adherent cells were washed with 10mL PBS and harvested
with 4mL PBS EDTA (1.5mM) per 10 cm dish. Suspension cells were directly transferred to a
50mL tube (TRP) and semi-adherent macrophages (RAW-264.7) were scraped. An aliquot of the
cell suspensionwas taken for a subsequent western blot.en, the cell suspensionwas centrifuged
for 3min at 1000 rpm, the supernatant was aspirated and cell pellets were frozen and stored at
−80℃. Aer thawing, 3 pellet volumes of buৰer A were added to the pellets. Aer 5min equili-
bration, the suspension was centrifuged at 5000 rpm and 4℃ for 5min. e resulting pellet was
resuspended in the 3 pellet volumes buৰer A*, incubated for 1–3min, and centrifuged again at
5000 rpm and 4℃ for 10min. e supernatant ”cytoplasmic extract” was pipeed in new Ep-
pendorf tubes. Aer resuspension of the pellet in buৰer B, the solution was rolled for 30min at
4℃. Non soluble cell debris was removed by centrifugation at 14000 rpm for 30min at 4℃. e
remaining supernatant was termed nuclear extract.
3.3.4 H2O2 treatment of U-2932 cells
U-2932 cell suspension was centrifuged for 3min at 1000 rpm and supernatant was aspirated. en
the pellet was resuspended with serum free medium or PBS containing 1mMH2O2 and cells were
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incubated for 10min at room temperature. ereaer, cells were centrifuged again for 3min at
1000 rpm, the supernatant was aspirated and the cell pellets were frozen and stored at−80℃.
3.3.5 Endotoxin stimulation
E. coli lipopolysaccharide (LPS) from Escherichia coli 055:B5 (Sigma, L2880) was directly added
to the cell culture medium for stimulation at a ৱnal concentration of 100ng/mL. e cells were
stimulated for 4 h and then harvested as described in paragraph 3.3.2.
3.3.6 Serum starvation
Cells grown in 6-well plates were treated when they reached 70-90% con৲uency. Firstly, the cells
were washed twice with 2mL DMEM without FCS. en 3mL DMEM without FCS was added to
the cells for the time indicated.
3.3.7 siRNA mediated gene knockdown
e transient knockdown of beclin-1 and p62 in A549 empty and BAL1 cells was carried out as
follows:
Day 0 Reverse transfection: 500µL OptiMem (Invitrogen) medium, 2µL of a 20 nM siRNA stock
(siCTR or siBecn-1, Ambion) and 4µL Lipofectamine RNAiMax (Invitrogen) were premixed
and incubated at RT for 20 min. A549 empty and BAL1 cells were seeded at a density of
5x10⁵ cells per well of a 6-well plate, mixed with the transfection mix and allowd to adhere
overnight.
Day 1 e medium was changed in the morning.
Day 2 or 3 e cells were harvested as described in paragraph 3.3.2 to control the success of the
knockdown bywestern blot using an antibody speciৱc for beclin-1 or p62. Alternatively, the
cells were ৱrst treated with serum starvation to induce autophagy as described in paragraph
3.3.6 and harvested subsequently.
e beclin-1 siRNA was a gi from C. Blenn, Institute of Pharmacology, Zurich. p62 siRNA was
synthesized byiagen according to the sequence p62-2 published in (115).
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3.4 Interaction studies
3.4.1 GST pull-down assay
GST pull-down assays were performed according to manufacturers procedure (Amersham/GE)
with Glutathione-Sepharose 4B a৳nity beads, and as described in the ৱgure legends. Brie৲y,
His puriৱed (His)₆-GST tagged macro domains were rebound for 2 h with 10-20µL Glutathione-
Sepharose (Amersham Biosciences, Sweden) in 1mL BB (50mMTris pH 7.5, 1% NP-40 and 250mM
NaCl) at 4℃.en the beads were washed 2x with WB1 (50mM Tris pH 7.5, 1% NP-40 and 250mM
NaCl) and WCE as decribed in 3.3.2 were prepared and incubated for 2 h with the beads, aer
adjustment of the NaCl concentration to 100mM. To reduce false positive interaction partners,
ethidium bromide (EtBr) at a concentration of 50µg/ml was added to the WCE before performing
the pull-down assay. Aer 3 washing steps with WB2 (50mM Tris pH 7.5, 0.2% NP-40 and 100mM
NaCl), the proteins were eluted with 60µL 2x LB at 95℃ for 3min and separated by SDS-PAGE as
described in 3.5.1.
3.4.2 Hemagglutinin-Co-Immunoprecipitation
Hemagglutinin-Immunoprecipitation (HA-IP)were performed as previously described (116). Brie৲y,
10-20µL HA-Agarose (Sigma, clone HA-7) were washed 2x with WB1 (50mM Tris pH 7.5, 1% NP-
40 and 250mMNaCl). Whole cell extracts (WCE) as decribed in 3.3.2 were prepared and incubated
with the beads for 2 h. Aer 3washing steps withWB2 (50mMTris pH 7.5, 0.2%NP-40 and 100mM
NaCl), the proteins were eluted with 60µL 2x LB at 95℃ for 3min and separated by SDS-PAGE
as described in 3.5.1.
3.5 Detection methods
3.5.1 SDS-PAGE
To separate a protein mixture according to their molecular weight, SDS-PAGE was performed. At
ৱrst, glass plates were cleaned with Ethanol (EtOH) and ddddH20. en a 10% separating gel was
cast using 1/4 (v/v) acrylamide (acrylamide-bis solution 37.5:1, 40% (w/v), SERVA Electrophore-
sis), 1/4 (v/v) solution B and ddH20 to the ৱnal amount. 1/100 (v/v) APS (10%) and 1/1000 (v/v)
TEMED were used to let the gel polymerize. On top of the separating gel, a 4% stacking gel was
cast and a comb to create the sample pockets was inserted before polymerization. Before usage,
sample pockets were rinsed with running buৰer to remove not polymerized acrylamide. Samples
were loaded into pockets and one lane was used to load a marker of distinct molecular weights.
e electrophoresis unit was ৱlled with running buৰer and run at 90–125V for an hour. When
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the bromphenol blue line reached the lower edge of the gel, the electrophoresis apparatus was
disconnected, disassembled and the gel was either stained (as described in paragraphs 3.5.2, 3.5.3)
or immunobloed (described in paragraph 3.5.4).
3.5.2 Silverstain
ewhole staining procedure was performed on a lab shaker at 100–200 rpm. e polyacrylamide
gel was washed for 30min in ddH2O and ৱxed for 10min in ৱxing solution. ereaer, the gel
was incubated for 5min in rinse solution and sensitized for 2min. Aer a short 2min wash in
ddH2O, the gel was stained for 20min, washed twice for 1min and developed for a maximum of
10min. e developer was changed aer one minute. Staining was stopped by incubation for at
least 5min in stop solution, thereaer, the PAGEs were washed three times with ddH2O.
3.5.3 Roti®-Blue
is sensitive colloidal coomassie G-250 staining solution with a low detection limit was prepared
according to manufacturer’s instructions (Roth). It’s based on a protocol described in (117). e
gels were incubated over night in a closed container and destained aerwards with ddH2O. Indi-
cated bands were cut out, transferred to Eppendorf tubes and stored at -20℃ until tandem mass
spectrometry was performed 3.5.6.
3.5.4 Western blot
Resolved proteins were transfered from the polyacrylamide gel onto a methanol activated PVDF
membrane (Immobilon-FL, Millipore) at a current of 100V for 1h or alternatively at 30 V over
night. Aer 1 h incubation in blocking solution 10% milk (Migros) in TBST) to avoid unspeciৱc
binding, the membrane was incubated for 2 h with the primary antibody diluted in TBST and
0.5% milk. Aerwards the membrane was washed 3 x with TBST and incubated for 1 h with the
appropriate secondary antibody. e membrane was washed again 3 x with TBST, drained and
developped with enhanced chemiluminescence (ECL) solution (Fisher Scientiৱc) and exposed to
X-ray ৱlm (Raymed Imaging, Typox TX-RP) for 1 s–15min. Phosphorylated proteins and LC3B
were detected by using phosphorylation speciৱc antibodies and the substrate SuperSignal West
Femto (Fisher Scientiৱc), an ultra sensitive ECL solution. To minimize background, the mem-
branes were blocked for 1h at RT in 5% milk (Migros)/3% bovine serum albumin (Sigma) in TBST)
and washed with TBST containing 2.5% milk (Migros) aer each incubation with antibodies. Be-
fore developing with the ECL substrate, the membrane was again 3 x washed with TBST (without
milk).
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3.5.5 antitative PCR
Total RNA from cells was isolated using TriReagent (Luzerna). Cells were washed with PBS and
0.5mL and TriReagent was added directly to a 6-well to resuspend cells by up and down pipeing.
e cell suspension was transfered to an Eppendorf tube, 0.1mL chloroform was added and the
tube was vortexed for 15 s. e suspension was incubated at room temperature until it was well
separated and then centrifuged at 12000 g for 15min at 4℃.e aqueous phase containing the RNA
was transferred to a new Eppendorf tube and mixed with 0.25mL isopropanol. Aer a centrifu-
gation step (12000 g, 10min, 4℃), the pellet was washed with 0.5mL 75% ethanol by vortexing and
centrifuged again (7500 g, 10min, 4℃). ereaer the RNA was air dried and dissolved in 10mM
Tris (pH 7.5). e RNA was subsequently reverse-transcribed using the ‘High-capacity cDNA
reverse transcription kit’ (Applied Biosystems). Real-time qPCR was performed using the Rotor-
Gene 3000 (Corbe Life Science) and SYBR Green according manufacturers protocols. Primers
used for ARTD9 FWD GGCAAAGAGGTCCAAGATGCTG and REV GCCTCACACATCTCTTC-
CACGT and GAPDH FWDGAAATCCCATCACCATCTTCC and REV GAGCCCCAGCCTTCTC-
CATG. Values were calculated according to the 2−∆Ct method and normalized to GAPDHmRNA.
Mean and standard deviation was calculated.
3.5.6 Tandem mass spectrometry
Liquid chromatography/electrospray ionisation/mass spectrometry/mass spectrometry (LC/ESI/
MS/MS) was carried out by the Functional Genomics Centre Zurich as follows.
Gel bands were cut in small pieces and washed 2 x with 100µL 100 mMNH4HCO3/50% acetonitrile
and again washed 1 x with 50 µL acetonitrile. All three supernatants were discarded. Digestion
was carried out by addition of 10 µL trypsin (10 ng/µl in 10 mM Tris/2 mM CaCl2, pH 8.2) together
with 20 µL buৰer (10 mM Tris/2 mM CaCl2, pH 8.2) at 37° C over night. Supernatant was removed
and gel pieces were extracted 2 x with 100 µL 0.1% TFA/50% acetonitrile. All three supernatants
were combined and dried. Samples were dissolved in 25 µL 0.1% formic acid and transferred to
autosampler vials for LC/MS/MS. 4 µL (9 µl for band 93 and 95) were injected.
Database searches were performed by using the ProteinLynx Global Server (SwissProt, all species)
and Mascot (NCBI_nr, all species; SwissProt, all species) search programs. Only Mascot results
are shown (PLGS results were essentially the same). Mascot results were summarized in Scaৰold
(trypsin, keratins and bait proteins were hidden).
Database searching
Charge state deconvolution and deisotoping were not performed. All MS/MS samples were ana-
lyzed using Mascot (Matrix Science, London, UK; version Mascot). Mascot was set up to search
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the fgcz_swissprot_20110111 database (unknown version, 524680 entries) assuming the digestion
enzyme trypsin. Mascot was searched with a fragment ion mass tolerance of 0.050 Da and a par-
ent ion tolerance of 10.0 PPM. Oxidation of methionine and acrylamide adduct of cysteine were
speciৱed in Mascot as variable modiৱcations.
Criteria for protein identification
Scaৰold (version 3.3.2, Proteome Soware Inc., Portland, OR) was used to validate MS/MS based
peptide and protein identiৱcations. Peptide identiৱcations were accepted if they could be estab-
lished at greater than 95.0% probability as speciৱed by the Peptide Prophet algorithm (Keller, A
et al Anal. Chem. 2002;74(20):5383-92) (118). Protein identiৱcations were accepted if they could
be established at greater than 95.0% probability and contained at least 1 identiৱed peptides. Pro-
tein probabilities were assigned by the Protein Prophet algorithm (, AI Anal Chem. 2003 Sep
1;75(17):4646-58) (119). Proteins that contained similar peptides and could not be diৰerentiated
based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.
3.6 In silico methods and soware
3.6.1 Multiple sequence alignments
A multiple sequence alignment (MSA) of ARTD7-9, mH2A1.1, mD1, mD2, C6orf130, Af1521 and
SARS nsp3 was made using the M-Coৰee web server (120–122). e MSA was reৱned using
ClustalX 2.1.
3.6.2 Domain structure prediction
BAL1/ARTD9 (NP_001139574.1, 854aa, human PARP9 isoform a), BAL2/ARTD8(NP_001034619.2,
1817aa, mouse PARP14) and BAL3/ARTD7(NP_001106995.1, 678 aa, human PARP15 isoform 1) FL
sequences were queried against InterPro (available online: http://www.ebi.ac.uk/Tools/
pfa/iprscan/) and domain bordersweremanually validatedwith Phyre (available online: http:
//www.sbg.bio.ic.ac.uk/~phyre/) (123).
3.6.3 Protein structure prediction and modeling
I-TASSER (available online: http://zhanglab.ccmb.med.umich.edu/I-TASSER/) (124) was
used to predict the structure of BAL1/ARTD9 (NP_001139574.1, 854aa, human PARP9 isoform a),
BAL2/ARTD8(NP_001034619.2, 1817aa, mouse PARP14) and BAL3/ARTD7(NP_001106995.1, 678
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aa, human PARP15 isoform 1) FL proteins . Subsequently, protein structures were modeled using
PyMOL 1.2r1 soware (125).
3.6.4 Soware
ClustalX 2.1 (multiple sequence alignments)
Scaৰold 3.2.2 (analysis of mass spectrometry data)
PyMOL 1.2r1 (125) (structure modeling)
Inkscape 0.47 (vectors)
Gimp 2.6 (graphics)
XƎTEX and BibTEX (desktop publishing and literature database)
LibreO৳ce (simple statistics)
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4 Results
4.1 Identification of macro domain specific interaction
partners
Only few protein-to-protein interaction partners of BAL proteins are characterized to date (for
details see introduction). To identify further macro domain speciﬁc interaction partners, a GST
pull-down approach with subsequent mass spectrometry analysis was established as shown in
Fig. 1.
Figure 1. Schematic representation of the established GST pull-down setup to identify further
interaction partners of BAL proteins.
At the beginning, single and tandemmacro domains cloned into the pETM33 vector were recom-
binantly expressed as His-GST fusions in bacteria. en GST pull-downs were performed with
mammalian cell extracts and the co-puriﬁed proteins were separated by SDS-PAGE according to
molecular weight. e polyacrylamide gels were analyzed aer silver staining and speciﬁc bands
were cut and sent to mass spectrometry for identiﬁcation. e identiﬁed proteins were then val-
idated by further GST pull-downs and HA-immunoprecipitations analyzed by western blot.
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4.1.1 Multiple sequence alignment
A multiple sequence alignment (MSA) of ARTD7-9, mH2A1.1, mD1, mD2, C6orf130, Af1521 and
SARS nsp3 was made using the M-Coৰee web server (120–122). M-Coৰee is a meta-server that
combines several multiple sequence alignment algorithms and using this strategy outperforms
other methods for MSA. Conserved blocks and diৰerences between the protein sequences of the
diৰerent macro domains are shown in Fig. 2.
Figure 2. Multiple sequence alignment of diৰerentmacro domains. Macro domain sequences
of ARTD7-9, mH2A1.1, mD1, mD2, C6orf130, Af1521 and SARS nsp3 were aligned using M-
Coৰee. Above the alignment column conservation is indicated. Identical residues are marked
with an asterisk, highly conserved residues with a colon (:). Residues important for ADPr
binding in Af1521 are indicated with arrows. Singlemacro domains of ARTD7–9 are referred
to as 7B, 8C, 9B.
A ৱrst overview reveals that the sequence ofmacro domains of viral, bacterial and human origin is
highly conserved. Speciৱc binding properties for the diৰerentmacro domains are inferred, since
the aspartic acid (D20) and asparagine (N34), that were found to be important for ADPr binding by
Af1521 (33) (indicated with arrows in Fig. 2), are not conserved inmacro domains 7A/B, 8B/C and
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9B. In contrast, these residues are conserved in themacro domains mH2A1.1 and mD2. e laer
two macro domains are therefore proposed to bind ADPr, while the former could have altered
binding properties.
4.1.2 Structure modeling
So far, only single domain structures of the BAL proteins are solved by X-ray crystallography.
I-TASSER (available online: http://zhanglab.ccmb.med.umich.edu/I-TASSER/) is one of
the most accurate public protein structure prediction servers as assessed by CASP7, 8 and 9 ex-
periments (124). To assess if the diৰerent binding paerns of the BAL proteins (cf. Fig. 2) and
their respectivemacro domains could be explained by their structure and to get an impression of
the overall BAL proteins, their structure was modeled with I-TASSER and viewed in PyMOL.
Estimated Tm-score and root-mean-square-deviation (RMSD) are measures of similarity of the
predicted models and are used to compare the structure of a predicted model relative to its native
state. Tm-score weighs the core matches stronger and is therefore more sensitive. ARTD7 was
modeled with an estimated accuracy of 0.30±0.10 TM-score and 18.1±2.4 Å RMSD. As assessed by
estimated Tm-score and the amount of coils to the number of sheets and helices predicted, this
models is only appropriate to give a rough structural overview. Since ARTD8 was modeled with
an estimated accuracy of 0.53±0.15 TM-score and 13.7±4.0ÅRMSD and the estimated accuracy for
ARTD9 was 0.51±0.15 TM-score and 12.6±4.3Å RMSD, these two models are expected to be in the
right fold (126). Stereo ribbon representations of the models are shown in Fig. 3.
Results 37
Figure 3. Stereo ribbon representation of the ARTD7-9 overall structure colored in a blue-to-
red gradient (from amino-terminus to carboxy-terminus). e ৱgures were prepared using
the soware PyMOL (125).
4.1.3 Expression of macro domains in bacteria
AF1521 wildtype (WT) and mH2A1.1 WT were intended as PAR and ARTD1 binding positive
controls, GST, AF1521 binding mutant (mut) and mH2A1.1 mut as negative controls. e macro
domain of macro D2, a mammalian protein of unknown function, was previously shown to bind
monomeric ADPr with high a৳nity (Kd = 0.15 µM). However, it did not bind PAR e৳ciently (29).
us, we chose it as mono-ADP-ribose binding control. Single macro domains of ARTD7–9 are
referred to as 7B, 8C, 9B. e two macro domains of ARTD9 expressed in tandem are termed
9Tm.
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Aer puriৱcation on nickel beads, proteins were separated by 10% SDS-PAGE and stained with
Comassie as shown in Fig. 4.
Figure 4. Expressed macrodomains were puriৱed on high performance nickel sepharose,
separated by 10% SDS-PAGE and stained with Coomassie blue. E1 and E2 indicate Elution 1
and Elution 2 respectively. e estimated molecular weight for His-GST-9Tm is ∼75 kD.
For the following GST pull-down experiments, the nickel puriৱed His-GST fusion proteins were
rebound to glutathione sepharose. en the beads were washed before mammalian cell extracts
were added to remove contaminating bacterial proteins. By this tandem a৳nity puriৱcation a
high purity of the fusion proteins was achieved (Fig. 5 and 9).
4.1.4 Optimization of NaCl concentration for GST pull-downs
To use a NaCl concentration for GST pull-downs that stabilizes speciৱc and reduces unspeciৱc
binding, salt concentration dependent interactions were analyzed for AF1521 WT and its binding
mutant (AF1521 mut) as well as for mH2A1.1 WT and mH2A1.1 mut.
GST was used as negative control. is pull-down was performed with untreated nuclear extract
from 293T cells. Aer boiling the beads in SDS Lämmli buৰer for 3min at 100℃, co-puriৱed
proteins were separated by SDS-PAGE and analyzed by silver staining (Fig. 5).
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Figure 5. Optimization of NaCl concentration for GST pull-downs. Nuclear 293T extracts
were bound at 125/250mM NaCl concentration to immobilized macro domains. 7.5% SDS-
PAGE silver stained. ARTD1 indicates the size of the band identiৱed by western blot (6) as
ARTD1.
e following GST pull-downs were performed at a NaCl concentration of 210mM, according
to the results of this optimization experiment. Of note is the high purity achieved aer rebind-
ing of the nickel puriৱed macro domain proteins to glutathione sepharose, as analyzed by silver
staining.
4.1.5 ARTD1 from untreated 293T extracts binds to mH2A1.1 and AF1521
macro domains
e interaction of ARTD1 with positive control macro domains was analyzed by western blot to
identify ARTD1 (Fig. 6).
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Figure 6. e same GST pull-down as in Fig. 5 analyzed by western blot against ARTD1.
AF1521 WT and mH2A1.1 WT bind ARTD1 at 125 and 250mM NaCl concentration. An un-
treated 293T extract was used as positive control (PC).
As previously published, AF1521 WT and mH2A1.1 WT bind ARTD1 and can therefore be used as
positive controls (33, 35). To prove this protein-to-protein interaction, complexes from the GST
pull-down in Fig. 5 were analyzed by western blot using an antibody against ARTD1. Since the
loss-of-binding mutants and GST do not interact with ARTD1 they were used as negative controls
for the following experiments.
4.1.6 Comparison to a mass spectrometry compatible stain
A mass spectrometry compatible staining solution with a high sensitivity, as recommended by
the Functional Genomics Center, was used to stain the samples of the GST pull-down described
above in section 4.1.4 (Fig. 7).
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Figure 7. 7.5% SDS-PAGE, Roti blue (Roth) colloidal G-250 Coomassie blue stain.
Although the sensitivity is high, interaction partners are less easy to identify than on a silver
stain. erefore further GST pull-downs were still ৱrst analyzed by silver stain, but an aliquot
was stored for mass spectrometry.
4.1.7 ARTD1 from untreated RAW-264.7 extracts binds to mH2A1.1 and
mD2, but not to the expressed BAL macro domains
SinceARTD1was previously described as interaction partner of the proteins AF1521 andmH2A1.1,
we wanted to investigate its co-precipitation properties with the ARTD7–9 macro domains and
mD2.
To investigate the binding partners of BALmacro domains, GST pull-downs were performed with
untreated RAW264.7 extracts. Aerwards co-puriৱed proteins were separated by SDS-PAGE and
analyzed by silver staining. To assess, whether the expressed BALmacro domains bind mono- or
poly-ADP-ribosylated endogenous ARTD1, themacro domain mD2was included as a mono-ADP-
ribose binding positive control, and the co-puriৱed proteins were analyzed by ARTD1 western
blot (Fig. 8).
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Figure 8. Untreated RAW-264.7 extracts were used for GST macro domain pull-downs. Le
panel: Co-puriৱed proteins were separated by 7.5% SDS-PAGE and silver stained. Right panel:
e same samples were analyzed by western blot against ARTD1.
is revealed that mD2 binds endogenous ARTD1, although to a lesser extent than mH2A1.1.
Conversely, endogenous ARTD1 was not detected in the complexes formed by the analyzed BAL
macro domains. Further GST pull-downs were performed with stimulated extracts to analyze, if
this is a detection-, treatment- or cell line-speciৱc characteristic of BAL macro domains.
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4.1.8 ARTD1 from LPS treated RAW-264.7 extracts binds to mH2A1.1 and
mD2, but not to the expressed BAL macro domains
GST pull-downs were performed with LPS-treated RAW264.7 extracts, to further investigate the
binding partners of the expressed BALmacro domains. Cells were treated for 4 h with 100 ng/mL
E. coli lipopolysaccharides (LPS) to induce mono- and poly-ADP-ribosylation (cf. the ARTD1-
smear in Fig. 10, which indicates PAR formation, to the ARTD1 band in Fig. 8), thereaer extracts
were prepared. en the GST pull-down was performed. Co-puriৱed proteins were separated by
SDS-PAGE and analyzed by silver staining and the indicated bands were selected for identiৱcation
by mass spectrometry (Fig. 9).
Figure 9. LPS treated RAW-264.7 extracts were pulled down with resin-bound GST macro
domains. Co-puriৱed proteins were separated by 7.5% SDS-PAGE and silver stained. On the
two lanes to the right reboundGSTmacro domainswithout addition of RAW-264.7 extracts are
loaded as additional negative controls. e indicated bands were selected for identiৱcation
by mass spectrometry.
To assess, whether BALmacro domains bindmono- or poly-ADP-ribosylated endogenous ARTD1,
the co-puriৱed proteins were analyzed by ARTD1 western blot (Fig. 10).
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Figure 10. Western blot analysis with an anti-ARTD1 antibody. e same samples as analyzed
by silver stain and shown in Fig. 9 were used.
Again, western blot anti-ARTD1 revealed thatmD2 binds endogenousARTD1, although to a lesser
extent than mH2A1.1. Reproducibly, endogenous ARTD1 could not be detected in the complexes
co-puriৱed with the analyzed BAL macro domains.
4.1.9 ARTD1 from H2O2 treated U-2932 extracts binds to mH2A1.1 and
mD2, but not to the expressed BAL macro domains
BAL proteins were originally identiৱed in DLBCL. We therefore assessed the interaction of the
expressedmacro domains with extracts from the U-2932 cell line. GST pull-downs were repeated
with H2O2 treated U-2932 DLBCL cell extracts. H2O2-treatment was used to enhance mono- and
poly-ADP-ribosylation of possible binding partners (11).
In a preliminary experiment, PAR formation aer H2O2-treatment was analyzed by western blot-
ting (Fig. 11).
Figure 11. Western blot analysis anti-ARTD1 and anti-PAR. U-2932 cells were incubated with
medium containing 1mM H2O2 for the indicated period. WCE were prepared, separated by
7.5% SDS-PAGE and analyzed by western blot. PC indicates a PAR positive control.
PAR formation was treatment and time dependent with a maximum at time point 10min. Inter-
estingly, also in untreated cells PAR formation was visible, although to a minor extent. For the
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following GST pull-down experiment, U-2932 cells were therefore treated for 10min with 1mM
H2O2. Co-puriৱed proteins were separated by SDS-PAGE and analyzed by silver staining (Fig. 12).
Figure 12. H2O2 treated U-2932 extracts were pulled down with resin-bound GST macro do-
mains. Co-puriৱed proteins were separated by 7.5% SDS-PAGE and silver stained. e indi-
cated bands were selected for identiৱcation by mass spectrometry.
To assess, whether BALmacro domains bindmono- or poly-ADP-ribosylated endogenous ARTD1,
the co-puriৱed proteins were again analyzed by ARTD1 western blot (Fig. 13).
Figure 13. Western blot analysis with an anti-ARTD1 antibody. e same samples as analyzed
by silver stain and shown in Fig. 12 were used.
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Western blot anti-ARTD1 revealed that mD2 binds endogenous ARTD1, although to a lesser ex-
tent than mH2A1.1. Reproducibly, the analyzed BAL macro domains didn’t bind endogenous
ARTD1 at all.
4.1.10 Identification of macro domain specific interaction partners by
tandem mass spectrometry
e gel bands indicated in Fig. 9 were cut and sent to the Functional Genomics Centre Zurich
(FGCZ). e interaction partners identiৱed by LC/ESI/MS/MS at the FGCZ are listed in Table 4.1.
Signiৱcant hits (Protein probability > 95% as analyzed by Scaৰold) for eachmacro domain are listed
above the black line. Proteins validated as interaction partners by western blot are indicated by a
plus (+) sign. Proteins with no entry in the validation column were not veriৱed by western blot.
A ৱrst overview revealed that the proteins tubulin, vimentin, nucleolin and heat shock cognate 71
protein were found to be interacting with ARTD9/BAL1 tandem (9Tm), ARTD7 and ARTD8macro
domains. ese proteins were previously described to be ADP-ribosylated and to be interaction
partners of ARTD1 (11, 37, 127, 128). is provided the ৱrst evidence that the established exper-
imental setup was working in the anticipated way. e method was therefore used for further
experiments.
As deduced from themultiple sequence alignment (cf. paragraph 4.1.1), distinct binding properties
were expected for the diৰerentmacro domains. ARTD1 was only detected as interaction partner
of mD2, but not of the other analyzed macro domains, underlining the previously conducted
analysis by western blot (cf. paragraph 4.1.8). p62/sequestosome-1, a protein involved in selective
autophagy and mutated in Paget’s disease of the bone, was speciৱcally detected as interaction
partner of 9Tm.
Another group of proteins detected comprises RNA associated helicases and heterogenous nu-
clear ribonucleoproteins (HNRPs) A/B, F, U and M. ese proteins were previously found to be
associated with ARTD1 and are thought to interact unspeciৱcally by binding to nucleic acids. To
test this hypothesis, the interaction between p68/RNA helicase DDX5 and the ARTD9/BAL1 was
reanalyzed by co-immunoprecipitation with addition of ethidium bromide (EtBr). EtBr abrogates
the nucleic acid-mediated interaction between proteins through intercalation and can therefore
remove false positive interaction partners in a pull-down assay (129).
Plasminogen Activator Inhibitor 1 RNA binding protein, Immune responsive gene 1, RuvB-like
1, Zinc ৱnger CCCH-type antiviral protein 1 (ZAP/ARTD13) and 54 kDa 2’-5’-oligoadenylate
synthase-like protein 2 form an antiviral cluster (130, 131). e gene of 2’-5’-oligoadenylate synthase-
like protein 2 was previously found to be upregulated upon ARTD9 overexpression (43). e de-
tection of the mentioned proteins as interaction partners underlines the antiviral properties of
macro ARTD 9 and 8.
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Table 4.1. Protein identiৱcation by LC/ESI/MS/MS, Functional Genomics Centre Zurich
(FGCZ). Identiৱcation of BALmacro domain interaction partners by tandem mass spectrom-
etry. Signiৱcant hits (Scaৰold probability > 95%) for each macro domain are listed above the
black lines.
Protein Accession Peptides Mass in kDa Validation
ARTD9/BAL1 tandem macro
β-Tubulin P07437 13 50
Nucleolin P09405 11 77 +
Plasminogen Activator Inhibitor 1 RNA binding protein Q6AXS5 3 45
Heterogenous nuclear ribonucleoprotein U Q00839 2 91
Tubulin α-1B chain P05213 2 50
Heterogenous nuclear ribonucleoprotein F P52597 1 46
Sequestosome-1 Q64337 1 48 +
ATP dependent RNA helicase DDX3X O00571 1 73
Nucleolar RNA helicase 2 Q3B8Q1 1 86
Immune responsive gene 1 P54987 1 54
RuvB-like 1 P60122 1 50
Heterogenous nuclear ribonucleoprotein M Q9D0E1 1 78
ARTD13/Zinc ৱnger CCCH-type antiviral protein 1 Q3UPF5 1 107 +
ARTD8/BAL2 macro C
Nucleolin P09405 14 77 +
Vimentin P20152 6 59
β-Tubulin P07437 3 50
Heterogenous nuclear ribonucleoprotein U Q00839 3 91
Nucleolar RNA Helicase 2 Q9JIK5 3 94
60S acidic ribosomal protein P0 P14869 2 34
p68/Probable ATP-dependent RNA helicase DDX5 A5A6J2 2 69 +
Heterogenous nuclear ribonucleoprotein A/B Q99020 1 31
RuvB-like 1 P60122 1 50
Immune responsive gene 1 P54987 1 54
Heterogenous nuclear ribonucleoprotein M Q9D0E1 1 78
ATP-dependent RNA Helicase DDX24 Q9ESV0 1 94
ARTD9/PARP9/BAL1 Q8IXQ6 1 96
ARTD13/Zinc ৱnger CCCH-type antiviral protein 1 Q3UPF5 1 107
Plasminogen Activator Inhibitor 1 RNA binding protein Q6AXS5 1 45
54 kDa 2’-5’-oligoadenylate synthase-like protein 2 Q9Z2F2 1 55
Sphingosine-1-phosphate lyase 1 A8R0X7 1 64
ARTD7/BAL3 macro B
Heat shock cognate 71 A2Q0Z1 1 71
Macro D2
ARTD1/PARP1 P11103 1 113 +
Interestingly, ARTD9 could be detected as interaction partner of the ARTD8macro domain. is
signiৱes that themacro domain containing ARTDs do not necessarily act alone, but can also form
dimers. is observation is in line with previously published data indicating that ARTD proteins
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can trans-modify each other (132, 133).
Validation of mass spectrometry results by western blot
Protein complexes from GST macro domain 9Tm and mD2 pull-downs with LPS treated RAW-
264.7 extracts were analyzed bywestern blot in order to validate the interaction partners identiৱed
by mass spectrometry. In Fig. 14 western blots with antibodies against nucleolin, ARTD10 and
ARTD13 are shown.
Figure 14. LPS treated RAW-264.7 extracts were pulled down with the indicated resin-bound
GST macro domains. Washed complexes were separated according to molecular weight on a
10% SDS-PAGE and analyzed by western bloing with antibodies against ARTD10, ARTD13
and nucleolin. EtBr and ADPr indicate the addition of ethidium bromide (EtBr) or ADP-ribose
(ADPr) to the pull-downs.
Ethidium bromide (EtBr) added to pull-down reactions was previously described to abrogate in-
teractions mediated by nucleic acids. e interaction between 9Tm and ARTD10 was interrupted
by EtBr and was therefore considered to be mediated by nucleic acids. In contrast, the interac-
tions with nucleolin and ARTD13 were speciৱc. In both cases, ADP-ribose (ADPr) addition could
not interrupt the interaction. is could identicate that the interaction is either not mediated by
ADPr or that free ADPr binds with lower a৳nity to themacro domain 9Tm.
In order to exclude that the observed interactions are mediated by bacterial bridging factors,
HA-co-immunoprecipitations were done with extracts from human A549 cells expressing empty
vector or HA-ARTD9. is approach veriৱed at the same time that the bacterially expressed fusion
proteins are folded correctly. To investigate, if ADP-ribosylation has an eৰect on the interaction,
one half of the cells was treated with LPS before preparing whole cell extracts. Using this assay,
ARTD1, nucleolin and the RNA helicase DDX5/p68 were veriৱed as interaction partners of full
length ARTD9 (Fig. 15), as well as ARTD13 and p62 (Fig. 16).
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Figure 15. Extracts fromA549 cells stably expressing HA-ARTD9 or an empty vector were co-
immunoprecipitated with HA-agarose. A549 cells were previously treated with LPS to stimu-
late ADP-ribosylation. Washed complexes were separated according to molecular weight on
a 10% SDS-PAGE and analyzed by western bloing with antibodies against ARTD1, nucleolin
and p68.
Figure 16. Extracts fromA549 cells stably expressing HA-ARTD9 or an empty vector were co-
immunoprecipitated with HA-agarose. A549 cells were previously treated with LPS to stimu-
late ADP-ribosylation. Washed complexes were separated according to molecular weight on
a 10% SDS-PAGE and analyzed by western bloing with antibodies against ARTD13 and p62.
p62 was the strongest interaction partner of ARTD9 as assessed by western blot. LPS-stimulation
increased the amount of ARTD1, ARTD13 and p68 bound toARTD9. In contrast, p62 and nucleolin
co-immunoprecipitated at lower levels, when cells were treated with LPS, then observed under
untreated conditions.
Ethidium bromide (EtBr) was added to the HA-immunoprecipitation reactions to further char-
acterize the nature of the interaction between ARTD9 and p62. As described above, ethidium
bromide abrogates interactions mediated by nucleic acids in pull-down assays. e interaction
between ARTD9 and p62 could not be interrupted by addditon of EtBr (Fig. 17).
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Figure 17. Extracts from A549 cells stably expressing HA-ARTD9 or an empty vector were
co-immunoprecipitated with HA-agarose. A549 cells were previously treated with H2O2 to
stimulate ADP-ribosylation where indicated. Complexes were washed, separated according
to molecular weight on a 10% SDS-PAGE, and analyzed by western bloing with antibodies
against HA and p62 and ubiquitin. EtBr indicates the addition of ethidium bromide to the
pull-downs.
is provides evidence that the interaction between ARTD9 and p62 is not mediated by nucleic
acids and therefore can be considered speciৱc.
To investigate and reproduce the observed eৰect of ADP-ribosylation induced by LPS (cf. Fig. 16),
the cells were additionally treated with H2O2, a strong ADP-ribosylation inducer, before prepa-
ration of extracts. H2O2 likewise reduced the interaction between ARTD9 and p62.
e complexes were also analyzed with an ubiquitin antibody, since mono-ubiquitinylation is a
prerequisite for proteins to bind p62 and further degradation by selective autophagy. is western
blot reveals that at least a subfraction of ARTD9 is mono-ubiquitinylated.
In summary, the above data indicate that p62 interacts ARTD9 over its macro domains. e in-
teraction could not be interrupted by EtBr. Additionally, a subfraction of ARTD9 was shown to
be mono-ubiquitinylated.
4.2 ARTD9 and autophagy
Since p62 is involved in several cellular processes including autophagy (see introduction), we
were curious if the interaction between ARTD9 and p62 has functional consequences. us, an
experimental setup to induce and monitor autophagy A549 cells was established.
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4.2.1 Starvation induces autophagy in A549 cells
To induce autophagy inA549 cells, serum starvationwas chosen, awell known autophagy inducer.
Starved A549 cells were harvested aer the indicated time and whole cell extracts were analyzed
by western blot with antibodies against phospho-p70S6 kinase (p-p70S6K), phospho-AMP kinase
(p-AMPK) and LC3B (Fig. 18).
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Figure 18. Time-course of starvation induced autophagy in A549 cells. Upper part: A549
cells were washed twice to remove remaining fetal calf serum (FCS) and thereaer incu-
bated for the indicated time in starvation medium (serum-free DMEM). WCE were prepared
and analyzed by western bloing with antibodies against phospho-p70S6 kinase (p-p70S6K),
phospho-AMP kinase (p-AMPK) and LC3B. Tubulin served as loading control. Lower part:
the corresponding quantiৱcation is depicted. Values are expressed relative to 0h (control).
Error bars represent standard deviation (SD), n = 3.
Already aer 0.5–1 h of starvation AMP kinase (AMPK) is phosphorylated, followed by the in-
activation of mTOR, which in turn de-phosphorylates p70S6 kinase (p70S6K). LC3B-II, a marker
of autophagic membrane, is detected in increased levels already aer 0.5–1 h and shows a peak
aer 4–6 h of starvation in A549 cells. Aer 4 h starvation AMPK phosphorylation is decreased
again, most probably due to ATP accumulation as result of induced autophagy. A second wave
of phosphorylation is initiated with the phosphorylation of AMPK at time point 12 h.
In summary, starvation induces autophagy in A549 cells in a time dependent manner. e estab-
lished experimental approach worked in the anticipated way. It allows to monitor autophagy, by
observation of autophagic signaling markers. e method was therefore used for further experi-
ments.
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4.2.2 Autophagy decreases ARTD9 levels in A549 cells
e next step was to explore, if induction of autophagy in৲uences ARTD9 levels or if ARTD9
has an eৰect on autophagy. is was carried out by using A549 cells stably expressing an empty
vector or full length human ARTD9 tagged with the hemagglutinin (HA) epitope tag. e cells
were incubated for the indicated duration in starvation medium, and extracts were analyzed by
western blot. A ৱrst overview reveals that basal autophagy is not signiৱcantly altered by ARTD9.
No diৰerence could be detected between LC3B-II levels of untreated A549 empty and A549 HA-
ARTD9 cells (Fig. 19, 0 h lanes).
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Figure 19. Time-course of autophagy induction in serum starved A549 empty and A549 HA-
ARTD9 cells. Upper part: cells were washed twice to remove remaining FCS and thereaer
incubated for the indicated time in starvation medium. WCE were prepared and analyzed
by western bloing with antibodies against hemagglutinin (HA), phospho-p70S6 kinase (p-
p70S6K), phospho-AMP kinase (p-AMPK) and LC3B. Tubulin was used as loading control.
Lower part: the corresponding quantiৱcation is shown. Values are expressed relative to 0h
(control). n = 3, error bars represent SD, * indicates p < 0.05, Student’s t-test.
e same holds true for induction of autophagy, as assessed by LC3B-II levels and AMPK and
p70S6K phosphorylation as well. In contrast, ARTD9 protein levels are signiৱcantly decreased
(p < 0.05) by 40% aer 4 h starvation.
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To further investigate and reproduce the observed eৰect of starvation induced autophagy on
ARTD9, A549 empty and A549 HA-ARTD9 cells were starved for prolonged durations (Fig. 20).
Figure 20. Time-course of autophagy induction in serum starved A549 empty and A549 HA-
ARTD9 cells. Cells were washed twice to remove remaining FCS and thereaer incubated
for the indicated time in starvation medium. WCE were prepared and analyzed by western
bloing with antibodies against hemagglutinin (HA), p62, phospho-p70S6 kinase (p-p70S6K),
phospho-AMP kinase (p-AMPK) and LC3B. Tubulin served as loading control. e values
below the HA immunoblot indicate the level of HA-ARTD9 (normalized to tubulin) relative
to 0h (control).
p62 functions as adaptor protein and substrate for selective autophagy and is therefore constantly
degraded. As described, its levels negatively correlated with LC3B-II levels.
In summary, markers for starvation induced autophagy in A549 were not signiৱcantly in৲uenced
by HA-ARTD9, but prolonged starvation decreased HA-ARTD9 protein levels by 80%.
4.2.3 ARTD9 messenger RNA levels in A549 cells aer starvation
To ascertain that this starvation induced decrease of HA-ARTD9 protein levels was not due to
decreased transcript levels of HA-ARTD9, ARTD9messenger RNAwas measured by reverse tran-
scription real time polymerase chain reaction (RT real time PCR). Aer the indicated duration of
starvation, ARTD9 mRNA levels were equal or higher than in the control samples (Fig. 21, 0 h).
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Figure 21. ARTD9 messenger RNA levels are equal or upregulated aer serum starvation.
Cells were washed twice to remove remaining FCS and thereaer incubated for the indicated
time in starvation medium. Total RNA was prepared and reverse transcribed. ARTD9 mRNA
levels were analyzed by real time PCR according to the 2−∆Ct method and normalized to
GAPDH mRNA. Values express the level of HA-ARTD9 relative to 0 h (control). Error bars
represent standard deviation (SD), n = 2.
is is consistent with a previous study, where the EF-1α promoter was described to be upregu-
lated by serum starvation in A. albopictus mosquito cells (134).
Altogether, this indicates that the observed decrease of ARTD9 protein aer starvation can not
be explained by reduced transcript levels and is most likely caused by induced autophagy.
4.2.4 siRNA mediated knockdown of p62 in A549 cells
Aer having established that (a) ARTD9 and p62 interact and (b) induction of autophagy decreases
ARTD9 protein levels, we examined if it would be possible to abrogate this eৰect by siRNA medi-
ated gene silencing of p62. For this reason, A549 cells stably expressing HA-ARTD9 were treated
with control and p62 siRNA and analyzed by western blot for p62 and HA-ARTD9 (Fig. 22).
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Figure 22. 48h aer silencing p62 is not detectable by western blot anymorewhile HA-ARTD9
levels appear increased under basal conditions. WCE were prepared and analyzed by western
bloing with antibodies against hemagglutinin (HA) and p62. e values below the HA im-
munoblot indicate the level of HA-ARTD9 (normalized to tubulin) relative to control. Tubulin
served as loading control. e experiment was performed once.
Tubulin was used as loading control. 48h aer silencing p62 was not anymore detectable by
western blot while HA-ARTD9 levels appeared increased under basal conditions.
Next, the cells silenced for p62 were starved for the indicated durations, to verify, if the p62
knockdown also abrogates the observed decrease of ARTD9 protein aer starvation. Again, WCE
were prepared and analyzed by western blot (Fig. 23).
Figure 23. HA-ARTD9 levels in p62-silenced cells appear not to decrease aer starvation.
Cells were washed twice to remove remaining FCS and thereaer incubated for the indicated
time in starvation medium. WCE were prepared and analyzed by western bloing with an-
tibodies against hemagglutinin (HA), p62, beclin-1, phospho-p70S6 kinase (p-p70S6K), and
LC3B. Tubulin served as loading control. e experiment was performed twice.
Silencing of p62 did not abrogate the induction of autophagy by serum starvation as analyzed by
the marker LC3B-II. e HA-ARTD9 levels in cells treated with the control siRNA were decreased
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aer starvation as observed in previous experiments. In contrast, in cells silenced for p62 the star-
vation induced decrease of HA-ARTD9 could not be observed (2–6 h starvation) or was reduced
(24 h starvation).
In summary, the experimental data give a hint that ARTD9 interacts with p62 and is degraded by
selective autophagy.
4.2.5 siRNA mediated knockdown of beclin-1 in A549 cells
Beclin-1 was silenced by siRNA mediated gene silencing, to further characterize the subpathway
involved in the degradation of ARTD9 by autophagy. For this reason, A549 cells stably expressing
HA-ARTD9were treatedwith control and beclin-1 siRNA and analyzed bywestern blot for beclin-
1, p62 and HA-ARTD9 (Fig. 24).
Figure 24. Beclin-1 silencing. 72h aer silencing beclin-1 is not detectable by western blot
anymore. WCE were prepared and analyzed by western bloing with antibodies against
hemagglutinin (HA), beclin-1 and p62. Tubulin served as loading control. e experiment
was performed once.
Tubulin was used as loading control. 72h aer silencing, beclin-1 was not anymore detectable by
western blot, but HA-ARTD9 levels appeared not in৲uenced under basal conditions.
To investigate, if the beclin-1 knockdownmight in৲uence the observed decrease of ARTD9 protein
aer starvation, the cells silenced for beclin-1 were starved for the indicated time. WCE were
prepared and analyzed by western blot (Fig. 25).
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Figure 25. Beclin-1 silencing does not alter the observed autophagy induction, nor the
degradation of HA-ARTD9 or p62. Cells were washed twice to remove remaining FCS and
thereaer incubated for the indicated time in starvation medium. WCE were prepared and
analyzed by western bloing with antibodies against hemagglutinin (HA), p62, beclin-1,
phospho-p70S6 kinase (p-p70S6K), and LC3B. Tubulin served as loading control. e experi-
ment was performed once.
Silencing of beclin-1 did not abrogate the induction of autophagy by serum starvation in A549
cells as analyzed by the marker LC3B-II and the observed decrease of p62. e HA-ARTD9 levels
in cells treated with the control siRNA and siRNA against beclin-1 were decreased aer starvation
as observed in previous experiments.
In summary, the experimental data suggest that starvation induced autophagy in A549 cells is
beclin-1 independent.
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5 Discussion
e aim of this project was to establish an unbiased approach to identify and functionally char-
acterize binding partners of both the full length macroARTD proteins as well as their respective
single and tandem macro domains. erefore, single and tandem macro domains cloned into the
pETM33 vector were expressed as His-GST fusion proteins in E. coli. Subsequently, GST pull-
downs were performed and the co-puriৱed proteins were separated by SDS-PAGE and analyzed
by silver staining. e bands representing probable interaction partners were selected for iden-
tiৱcation by mass spectrometry. e identiৱed proteins where then validated by further GST
pull-downs and HA-immunoprecipitations analyzed by western blot.
Previously, ARTD1 was shown as interaction partner of several macro domain containing pro-
teins, namely AF1521, mH2A1.1 and ALC1 (33, 35, 36, 38). Since macroD2 bound mono-ADP-
ribose with high a৳nity, but did not bind PAR e৳ciently (29), we included it in the set of parallel
pull-downs as a mono-ADP-ribose binding control. To investigate, if BAL macro domains have
diৰerent binding properties as single or in tandem, we also expressed 9Tm, the tandem macro
domains of ARTD9.
ereaer, we performed GST macro domain pull-downs with unstimulated and LPS stimulated
RAW-264.7 extracts. e analysis of the silver stained gels shows diৰering band paerns be-
tween the diৰerent macro domains. Diৰerences exist also between single and tandem macro
domains. Additionally, we discovered that mD2 interacts with ARTD1, using western blots to
identify ARTD1, but no interaction of the expressed BAL macro domains with ARTD1 could be
detected under the observed conditions. In addition, these results are consistent with the ones
inferred from the multiple sequence alignment. To rule out a cell line speciৱc eৰect, the GST pull-
downs were repeated with extract of the U-2932 cell line. is time we used H2O2 treatment to
induce mono- and poly-ADP-ribosylation. But again, western bloing against ARTD1 revealed
no interaction of the expressed BALmacro domains with ARTD1 under the observed conditions.
Also by mass spectrometry, ARTD1 could only be detected as interaction partner of mD2, but not
as interaction partner of the expressed BALmacro domains. If the expressed BALmacro domains
might be incorrectly folded, in contrary to themacro domains mH2A1.1 and mD2 expressed under
the same conditions, is described in the paragraphs below.
EtBr was added to the pull-downs and HA-immunopreciptiations to abrogate interactions medi-
ated by nucleic acids, in an aempt to eliminate false positive interaction partners. Using this
method, nucleolin and ARTD13 could be detected as speciৱc interaction partners of 9Tm.
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Hemagglutinin (HA)-tagged full length ARTD9 protein was stably expressed in (human) A549
cells for three reasons. First, to exclude that the identiৱed interactions with the macro domains
are mediated by bacterial contamination functioning as bridging factor. Second, to rule out that
the interaction partners identiৱed are unspeciৱc due to incorrect folding of the recombinantly
expressed macro domain proteins. ird, it also served to additionally reproduce and investigate
the observed interaction partners of the GST macro domains with the full length ARTD9/BAL1
protein by HA-immunoprecipitation.
Using this approach, p62, ARTD13, nucleolin and p68/DDX5 were validated as interaction part-
ners of ARTD9. Unexpectedly, ARTD1 could be detected as interaction partner of ARTD9 by
western blot, as well. is data could be explained by the di৳culty to ionize peptides of ARTD1
during mass spectrometry (personal communication P. O. Hassa). Another explanation would
be that the western blot against ARTD1 was developed using Pierce SuperSignal West Pico, an
enhanced chemiluminescence substrate with higher sensitivity than the previously used Pierce
ECL. Another explanation could be that the interaction of ARTD9 with ARTD1 is not mediated by
the tandem macro domains of ARTD9. Since the interactions between recombinantly expressed
9Tm and ARTD13, p68/DDX5, nucleolin and p62 could be reproduced with full length ARTD9, the
possibility that the BAL macro domains are incorrectly folded appears unlikely.
e interaction between p62 and ARTD9was the strongest, as observed bywestern blot. Since p62
is an adapter protein targeting ubiquitinylated proteins for degradation by selective autophagy,
we analyzed, if ARTD9 is ubiquitinylated,. Indeed, a subfraction of ARTD9 was proven to be
mono-ubiquitinylated, as analyzed by an anti-ubiquitin western blot.
We then asked, if the interaction of ARTD9 with p62 has functional implications. e eৰect of in-
duced autophagy onARTD9was investigated, since a subfraction of ARTD9 ismono-ubiquitinylated
and p62 targets ubiquitinylated proteins to the lysosome. Serum starvation as a well known in-
ducer of autophagy was used to treat A549 cells expressing HA-ARTD9. Induction of autophagy
was veriৱed by the analysis of several markers including LC3 turnover. Using this assay, HA-
ARTD9 protein levels were reduced signiৱcantly by 40% aer 4 h starvation. e degradation
rate found for ARTD9 in this study is comparable to the one found recently for the connexins
CX43 and CX50 (135).
To investigate if this decrease is p62 dependent, p62 was silenced by siRNA mediated gene silenc-
ing. Using siRNA against p62, the observed reduction of ARTD9 could be abolished and basal
ARTD9 levels were increased although autophagy could still be induced in A549 cells. is pro-
vides evidence that the observed decrease of ARTD9 aer starvation-induced autophagy is indeed
p62 dependent.
To characterize the autophagy pathway responsible for degradation of ARTD9, Beclin-1 was then
silenced by siRNA mediated gene silencing. Basal ARTD9 levels as well as the starvation induced
autophagywere not aৰected by the Beclin-1 knockdown inA549 cells. is suggests that ARTD9 is
degraded by p62 dependent but beclin-1 independent selective autophagy, since siRNA-mediated
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silencing of beclin-1 could not inhibit autophagy in A549 cells as well as the observed decrease of
ARTD9 and p62.
As mentioned above (see Introduction, section 1.1.3), ARTD9/BAL1 was reported as co-activator
of STAT1 and repressor for IRF1, an important IFNγ induced target gene of STAT1 (50). At the
same time, IFNγ induces autophagy and the expression of ARTD9/BAL1 as well (see Introduction,
section 1.4 and 1.1.2 for details). p62 is a signaling adaptor and interacts with atypical protein
kinase C (PKC), thereby positively regulating NF-κB mediated cytokine signaling downstream of
various receptors (136). Recently, the degradation of BCL10 by p62-dependent selective autophagy
was reported to protect T cells from aberrant NF-κB signaling in an analogous manner (137).
is prompts speculation that p62 could also be required for activation of IFNγ/STAT1 signaling
cascades in a similar way.
On the other hand, ARTD9/BAL1 degradation by selective autophagy could also be a negative
feedback loop to modulate IFNγ/STAT1 signaling. ARTD9 is detected 6-12 h aer IFNγ treatment
(personal communication R. Camicia). is is early compared to the reported late increase of p62
transcripts and protein levels in RAW264.7 macrophages aer 24 h of IFNγ treatement (138). e
same authors also report that p62 negatively regulates the expression of IL-12p40, a subunit of the
cytokine IL-12 that shis CD4+ cell development to a1 phenotype (139). is negative feedback
loop could contribute to the homeostasis between activation and suppression of innate immunity
and prevent adverse consequences like in৲ammatory disorders and cancer (2) that are related to
unrestrained activation of ARTD9/BAL1 dependent signaling and gene expression (44).
In a nutshell, the data presented in this thesis suggest that ARTD9 interacts with p62 over its
macro domains and is mono-ubiquitinylated. ARTD9 was reduced signiৱcantly by 40% aer 4 h
starvation in a p62 dependent but beclin-1 independent way. erefore, ARTD9 is most likely
degraded by p62 dependent but beclin-1 independent selective autophagy.
5.1 Outlook
PARP (ARTD) inhibitors are already in clinical trials as treatment for cancer (140). ARTD9 levels
correlate with chemoresistance in DLBCL, and ARTD8 was shown to protect against IL-4 induced
apoptosis (14, 42), but the extent to which BAL proteins contribute to cancer or adverse reactions
during its treatment with these inhibitors remains to be further elucidated.
Furthermore, expression of the BAL macro domains in insect or mammalian cells and following
interaction studies would be interesting to perform and to conৱrm the interactions found in this
study. In addition, the expression of large amounts of the tandem or triplet macro domains of
BAL proteins and subsequent X-ray crystallography could give structural and functional insights
into their mechanism.
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In this context, it would be interesting to conৱrm that the observed decrease of ARTD9 aer
starvation is indeed due to autophagy. is could be tested in an experiment using siRNA against
Atg7 or Atg5, proteins known to inhibit beclin-1 independent autophagy. If conৱrmed, it would be
interesting to investigate the eৰect of IFNγ, an inducer of autophagy as well as ARTD9/BAL1.
Of note, SUDHL7, the cell line where high ARTD9/BAL1 levels were detected (15), is reported on
the Sanger Institute Catalogue Of Somatic Mutations In Cancer to have a mutation in PTEN (141).
As described in the introduction, loss-of-function mutations in PTEN can activate mTORC1 and
inhibit autophagy. is might be an explanation for the high ARTD9 levels observed in this cell
line.
Another question to prove is, how ARTD9 and p62 interact. p62 binds to mono-ubiquitinylated
proteins as published previously and a subfraction of ARTD9was shown to bemono-ubiquitinylated
in this study. On the other hand it would be very interesting to investigate if p62 is ADP-
ribosylated, since it interacts with the macro domains of ARTD9. Since ARTD9 was published
to be catalytically inactive other enzymes would have to ADP-ribosylate p62 (43). In this screen
ARTD1, ARTD8 and ARTD13 were identiৱed as interaction partners of ARTD9. Like ARTD9,
ARTD13 is thought to be inactive, but ARTD1 and ARTD8 would be interesting candidates (17).
A ৱrst hint in this direction could be, that LPS and H2O2 treatment reduced the interaction be-
tween ARTD9 and p62 (Fig. 16 and 17).
Last but not least it would be interesting to investigate, if other ARTD proteins are degraded by
autophagy or in৲uence autophagy.
62
References
[1] Lodish, H., Berk, A., Kaiser, C. A., Krieger, M., Sco, M. P., Bretscher, A., Ploegh, H., and
Matsudaira, P. (2007) Molecular Cell Biology, W. H. Freeman, 6th edition.
[2] Karin, M., Lawrence, T., and Nizet, V. (2006) Innate immunity gone awry: linking microbial
infections to chronic in৲ammation and cancer. Cell, 124(4), 823–835.
[3] Corda, D. and Di Girolamo, M. (2002) Mono-ADP-ribosylation: a tool for modulating im-
mune response and cell signaling. Science’s STKE, 2002(163), pe53.
[4] Hassa, P. O. and Hoiger, M. O. (2008) e diverse biological roles of mammalian PARPS,
a small but powerful family of poly-ADP-ribose polymerases.. Frontiers in bioscience: a
journal and virtual library, 13, 3046.
[5] Deribe, Y. L., Pawson, T., and Dikic, I. (2010) Post-translational modiৱcations in signal in-
tegration. Nature structural & molecular biology, 17(6), 666–672.
[6] Levine, B., Mizushima, N., and Virgin, H. W. (2011) Autophagy in immunity and in৲amma-
tion. Nature, 469(7330), 323–335.
[7] Saitoh, T. and Akira, S. (2010) Regulation of innate immune responses by autophagy-related
proteins.e Journal of cell biology, 189(6), 925–935.
[8] Deretic, V. (2005) Autophagy in innate and adaptive immunity.Trends in immunology, 26(10),
523–528.
[9] Deretic, V. and Levine, B. (2009) Autophagy, immunity, and microbial adaptations. Cell host
& microbe, 5(6), 527–549.
[10] van der Heden van Noort, G. J., van der Horst, M. G., Overklee, H. S., van der Marel,
G. A., and Filippov, D. V. (2010) Synthesis of Mono-ADP-Ribosylated Oligopeptides Using
Ribosylated Amino Acid Building Blocks. Journal of the American Chemical Society, 132(14),
5236–5240.
[11] Hassa, P., Haenni, S., Elser, M., and Hoiger, M. (2006) Nuclear ADP-ribosylation reac-
tions in mammalian cells: where are we today and where are we going?.Microbiology and
molecular biology reviews, 70(3), 789.
References 63
[12] Hoiger, M. O., Hassa, P. O., Lüscher, B., Schüler, H., and Koch-Nolte, F. (2010) Toward a
uniৱed nomenclature for mammalian ADP-ribosyltransferases. Trends in Bioemical Sci-
ences, 35(4), 208–219.
[13] Oo, H., Reche, P., Bazan, F., Dimar, K., Haag, F., and Koch-Nolte, F. (2005) In silico char-
acterization of the family of PARP-like poly (ADP-ribosyl) transferases (pARTs). BMC ge-
nomics, 6(1), 139.
[14] Aguiar, R. C. T., Takeyama, K., He, C., Kreinbrink, K., and Shipp, M. A. (2005) B-aggressive
lymphoma family proteins have unique domains that modulate transcription and exhibit
poly (ADP-ribose) polymerase activity. Journal of Biological Chemistry, 280(40), 33756.
[15] Aguiar, R. C. T., Yakushijin, Y., Kharbanda, S., Salgia, R., Fletcher, J. A., and Shipp, M. A.
(2000) BAL is a novel risk-related gene in diৰuse large B-cell lymphomas that enhances
cellular migration. Blood, 96(13), 4328.
[16] Hakmé, A., Huber, A., Dollé, P., and Schreiber, V. (2008) e macroPARP genes Parp-9 and
Parp-14 are developmentally and diৰerentially regulated in mouse tissues. Developmental
Dynamics, 237(1), 209–215.
[17] Kleine, H., Poreba, E., Lesniewicz, K., Hassa, P. O., Hoiger, M. O., Litchৱeld, D. W., Shilton,
B. H., and Lüscher, B. (2008) Substrate-assisted catalysis by PARP10 limits its activity to
mono-ADP-ribosylation. Molecular Cell, 32(1), 57–69.
[18] Leung, A. K., Vyas, S., Rood, J. E., Bhutkar, A., Sharp, P. A., Chang, P., et al. (2011) Poly (ADP-
ribose) regulates stress responses and microRNA activity in the cytoplasm..Molecular cell,
42(4), 489.
[19] Aravind, L. (2001) e WWE domain: a common interaction module in protein ubiquitina-
tion and ADP ribosylation. Trends in Bioemical Sciences, 26(5), 273–275.
[20] Wang, Z., Michaud, G. A., Cheng, Z., Zhang, Y., Hinds, T. R., Fan, E., Cong, F., and Xu, W.
(2012) Recognition of the iso-ADP-ribose moiety in poly (ADP-ribose) by WWE domains
suggests a general mechanism for poly (ADP-ribosyl) ation-dependent ubiquitination. Sci-
ence’s STKE, 26(3), 235.
[21] Dominguez, G., Wang, C. Y., and Frey, T. K. (1990) Sequence of the genome RNA of rubella
virus: Evidence for genetic rearrangement during togavirus evolution. Virology, 177(1),
225–238.
[22] Gorbalenya, A. E., Koonin, E. V., and Lai, M. M. C. (1991) Putative papain-related thiol
proteases of positive-strand RNA viruses Identiৱcation of rubi-and aphthovirus proteases
and delineation of a novel conserved domain associated with proteases of rubi-, α-and
coronaviruses. FEBS Leers, 288(1-2), 201–205.
64 References
[23] Angelov, D., Molla, A., Perche, P. Y., Hans, F., Coté, J., Khochbin, S., Bouvet, P., and Dimitrov,
S. (2003) e histone variant macroH2A interferes with transcription factor binding and
SWI/SNF nucleosome remodeling.Molecular Cell, 11(4), 1033–1041.
[24] Pehrson, J. R. and Fried, V. A. (1992)MacroH2A, a core histone containing a large nonhistone
region. Science, 257(5075), 1398.
[25] Pehrson, J. R. and Fuji, R. N. (1998) Evolutionary conservation of histone macroH2A sub-
types and domains. Nucleic Acids Resear, 26(12), 2837.
[26] Martzen, M. R., McCraith, S. M., Spinelli, S. L., Torres, F. M., Fields, S., Grayhack, E. J.,
and Phizicky, E. M. (1999) A biochemical genomics approach for identifying genes by the
activity of their products. Science, 286(5442), 1153.
[27] Allen, M. D., Buckle, A. M., Cordell, S. C., Löwe, J., and Bycro, M. (2003) e crystal struc-
ture of AF1521 a protein from Archaeoglobus fulgidus with homology to the non-histone
domain of macroH2A. Journal of Molecular Biology, 330(3), 503–511.
[28] Shull, N. P., Spinelli, S. L., and Phizicky, E. M. (2005) A highly speciৱc phosphatase that acts
on ADP-ribose 1”-phosphate, a metabolite of tRNA splicing in Saccharomyces cerevisiae.
Nucleic acids resear, 33(2), 650.
[29] Neuvonen, M. and Ahola, T. (2009) Diৰerential activities of cellular and viral macro domain
proteins in binding of ADP-ribosemetabolites. Journal of Molecular Biology, 385(1), 212–225.
[30] Peterson, F. C., Chen, D., Lytle, B. L., Rossi, M. N., Ahel, I., Denu, J. M., and Volkman, B. F.
(2011) Orphan Macrodomain Protein (Human C6orf130) Is an O-Acyl-ADP-ribose Deacy-
lase. Journal of Biological Chemistry, 286(41), 35955–35965.
[31] Snijder, E. J., Bredenbeek, P. J., Dobbe, J. C., iel, V., Ziebuhr, J., Poon, L. L. M., Guan, Y.,
Rozanov, M., Spaan, W. J. M., and Gorbalenya, A. E. (2003) Unique and conserved features of
genome and proteome of SARS-coronavirus, an early split-oৰ from the coronavirus group
2 lineage. Journal of Molecular Biology, 331(5), 991–1004.
[32] Egloৰ, M. P., Malet, H., Putics, Á., Heinonen, M., Dutartre, H., Frangeul, A., Gruez, A.,
Campanacci, V., Cambillau, C., Ziebuhr, J., et al. (2006) Structural and functional basis for
ADP-ribose and poly (ADP-ribose) binding by viral macro domains. Journal of Virology,
80(17), 8493.
[33] Karras, G. I., Kustatscher, G., Buhecha, H. R., Allen, M. D., Pugieux, C., Sait, F., Bycro, M.,
and Ladurner, A. G. (2005) e macro domain is an ADP-ribose binding module.e EMBO
Journal, 24(11), 1911–1920.
[34] Gamble, M. J. and Kraus, W. L. (2010) Multiple facets of the unique histone variant
macroH2A: From genomics to cell biology. Cell cycle, 9(13).
References 65
[35] Kustatscher, G., Hothorn, M., Pugieux, C., Scheৰzek, K., and Ladurner, A. G. (2005) Splicing
regulates NAD metabolite binding to histone macroH2A. Nature Structural & Molecular
Biology, 12(7), 624–625.
[36] Ahel, D., Horejsi, Z., Wiechens, N., Polo, S. E., Garcia-Wilson, E., Ahel, I., Flynn, H., Skehel,
M., West, S. C., Jackson, S. P., et al. (2009) Poly (ADP-ribose)-dependent regulation of DNA
repair by the chromatin remodeling enzyme ALC1. Science, 325(5945), 1240.
[37] Dani, N., Stilla, A., Marchegiani, A., Tamburro, A., Till, S., Ladurner, A. G., Corda, D., and
Di Girolamo, M. (2009) Combining a৳nity puriৱcation by ADP-ribose-binding macro do-
mainswithmass spectrometry to deৱne themammalianADP-ribosyl proteome. Proceedings
of the National Academy of Sciences, 106(11), 4243.
[38] Goschalk, A. J., Timinszky, G., Kong, S. E., Jin, J., Cai, Y., Swanson, S. K., Washburn,
M. P., Florens, L., Ladurner, A. G., Conaway, J. W., and Conaway, R. C. (2009) Poly(ADP-
ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler.
Proceedings of the National Academy of Sciences, 106(33), 13770–13774.
[39] Baus, D., Nonnenmacher, F., Jankowski, S., Döring, C., Bräutigam, C., Frank, M., Hansmann,
M. L., and Pৱtzner, E. (2009) STAT6 and STAT1 are essential antagonistic regulators of cell
survival in classical Hodgkin lymphoma cell line. Leukemia, 23(10), 1885–1893.
[40] Goenka, S. and Boothby, M. (2006) Selective potentiation of Stat-dependent gene expres-
sion by collaborator of Stat6 (CoaSt6), a transcriptional cofactor. Proceedings of the National
Academy of Sciences, 103(11), 4210–4215.
[41] Mehrotra, P., Riley, J., Patel, R., Li, F., Voss, L., and Goenka, S. (2010) PARP-14 functions as
a transcriptional switch for STAT6 dependent gene activation. Journal of Biological Chem-
istry,.
[42] Cho, S. H., Goenka, S., Heninen, T., Gudapati, P., Reinikainen, A., Eischen, C. M., Lahes-
maa, R., and Boothby, M. (2009) PARP-14, a member of the B aggressive lymphoma family,
transduces survival signals in primary B cells. Blood, 113(11), 2416.
[43] Juszczynski, P., Kutok, J. L., Li, C., Mitra, J., Aguiar, R. C. T., and Shipp, M. A. (2006) BAL1
and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are
overexpressed in diৰuse large B-cell lymphomas with a prominent in৲ammatory inৱltrate.
Molecular and Cellular Biology, 26(14), 5348.
[44] Camicia, R. and Bachmann, S. B. and Winkler, H. C. and Hassa, P. O. B-aggressive lym-
phoma protein BAL1/ARTD9 inhibits tumor suppressor IRF1 and activates oncogene BCL6
to mediate survival in diৰuse large B-cell lymphoma. Submied.
[45] Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J., and Paul, W. E. (1999) e IL-4 receptor:
signaling mechanisms and biologic functions.Annual Review of Immunology, 17(1), 701–738.
66 References
[46] Shuai, K. and Liu, B. (2003) Regulation of JAK–STAT signalling in the immune system. Na-
ture Reviews Immunology, 3(11), 900–911.
[47] Darnell Jr, J. E. (1997) STATs and gene regulation. Science, 277(5332), 1630.
[48] Mosmann, T. R. and Sad, S. (1996) e expanding universe of T-cell subsets: 1, 2 and
more. Immunology Today, 17(3), 138–146.
[49] Aaronson, D. S. and Horvath, C. M. (2002) A road map for those who don’t know JAK-STAT.
Science, 296(5573), 1653.
[50] Liu, K. D., Gaৰen, S. L., and Goldsmith, M. A. (1998) JAK/STAT signaling by cytokine recep-
tors. Current opinion in immunology, 10(3), 271–278.
[51] Taniguchi, T., Ogasawara, K., Takaoka, A., and Tanaka, N. (2001) IRF family of transcription
factors as regulators of host defense. Annual review of immunology, 19(1), 623–655.
[52] Shi, L., Perin, J. C., Leipzig, J., Zhang, Z., and Sullivan, K. E. (2011) Genome-wide analysis
of interferon regulatory factor I binding in primary human monocytes. Gene,.
[53] Romeo, G., Fiorucci, G., Chiantore, M. V., Percario, Z. A., Vannucchi, S., and Aৰabris, E.
(2002) Review: IRF-1 as a negative regulator of cell proliferation. Journal of interferon &
cytokine resear, 22(1), 39–47.
[54] Yoshimura, A., Naka, T., and Kubo, M. (2007) SOCS proteins, cytokine signalling and im-
mune regulation. Nature Reviews Immunology, 7(6), 454–465.
[55] Shuai, K. (2000) Modulation of STAT signaling by STAT-interacting proteins. Oncogene,
19(21), 2638–2644.
[56] Tanaka, T., Soriano, M. A., and Grusby, M. J. (2005) SLIM is a nuclear ubiquitin E3 ligase
that negatively regulates STAT signaling. Immunity, 22(6), 729–736.
[57] Schindler, C., Levy, D. E., and Decker, T. (2007) JAK-STAT signaling: from interferons to
cytokines. Journal of Biological Chemistry, 282(28), 20059.
[58] Lenz, G. and Staudt, L. M. (2010) Aggressive lymphomas. New England Journal of Medicine,
362(15), 1417–1429.
[59] Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell,
144(5), 646–674.
[60] Kumar, V., Abbas, A. K., Fausto, N., and Aster, J. (2009) Robbins and Cotran Pathologic Basis
of Disease, Professional Edition, Saunders, 8th edition.
[61] Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., and Parkin, D. M. (2010) Estimates
of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer,
127, 2893–2917.
References 67
[62] Coussens, L. M. and Werb, Z. (2002) In৲ammation and cancer. Nature, 420(6917), 860–867.
[63] Roman, E. and Smith, A. G. (2011) Epidemiology of lymphomas. Histopathology, 58(1), 4–14.
[64] Murawski, N. and Pfreundschuh, M. (2010) New drugs for aggressive B-cell and T-cell lym-
phomas.e Lancet Oncology, 11(11), 1074–1085.
[65] Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick,
J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) Distinct types of diৰuse large B-cell lymphoma
identiৱed by gene expression proৱling. Nature, 403(6769), 503–511.
[66] Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne,
R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002)e use of molecu-
lar proৱling to predict survival aer chemotherapy for diৰuse large-B-cell lymphoma.New
England Journal of Medicine, 346(25), 1937.
[67] Sarosiek, K. A., Nechushtan, H., Lu, X., Rosenbla, J. D., and Lossos, I. S. (2009) Interleukin-
4 distinctively modiৱes responses of germinal centre-like and activated B-cell-like diৰuse
large B-cell lymphomas to immuno-chemotherapy. British Journal of Haematology, 147(3),
308–318.
[68] Lu, X., Nechushtan, H., Ding, F., Rosado, M. F., Singal, R., Alizadeh, A. A., and Lossos, I. S.
(2005) Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in
germinal center B-cell-like and activated B-cell-like diৰuse large-cell lymphomas. Blood,
105(7), 2924.
[69] Johansen, T. and Lamark, T. (2011) Selective autophagy mediated by autophagic adapter
proteins. Autophagy, 7(3), 279.
[70] Mizushima, N., Levine, B., Cuervo, A. M., and Klionsky, D. J. (2008) Autophagy ৱghts disease
through cellular self-digestion. Nature, 451(7182), 1069–1075.
[71] Xie, Z. and Klionsky, D. J. (2007) Autophagosome formation: core machinery and adapta-
tions. Nature cell biology, 9(10), 1102–1109.
[72] Levine, B. and Kroemer, G. (2008) Autophagy in the pathogenesis of disease. Cell, 132(1),
27–42.
[73] Mizushima, N. and Komatsu, M. (2011) Autophagy: renovation of cells and tissues. Cell,
147(4), 728–741.
[74] Backer, J. M., Bourret, L., and Dice, J. F. (1983) Regulation of catabolism of microinjected
ribonuclease A requires the amino-terminal 20 amino acids. Proceedings of the National
Academy of Sciences, 80(8), 2166.
68 References
[75] Wing, S. S., Chiang, H. L., Goldberg, A. L., and Dice, J. F. (1991) Proteins containing peptide
sequences related to Lys-Phe-Glu-Arg-Gln are selectively depleted in liver and heart, but
not skeletal muscle, of fasted rats.. Bioemical journal, 275(Pt 1), 165.
[76] Kroemer, G., Mariño, G., and Levine, B. (2010) Autophagy and the integrated stress response.
Molecular cell, 40(2), 280–293.
[77] Harris, J., Master, S., De Haro, S., Delgado, M., Roberts, E., Hope, J., Keane, J., and Deretic,
V. (2009) 1-2 polarisation and autophagy in the control of intracellular mycobacteria
by macrophages. Veterinary immunology and immunopathology, 128(1-3), 37–43.
[78] Feng, C. G., Zheng, L., Jankovic, D., Báৱca, A., Cannons, J. L., Watford, W. T., Chaussabel, D.,
Hieny, S., Caspar, P., Schwartzberg, P. L., et al. (2008) e immunity-related GTPase Irgm1
promotes the expansion of activated CD4+ T cell populations by preventing interferon-γ-
induced cell death. Nature immunology, 9(11), 1279–1287.
[79] Khalkhali-Ellis, Z., Abbo, D. E., Bailey, C. M., Goossens, W., Margaryan, N. V., Gluck,
S. L., Reuveni, M., and Hendrix, M. J. C. (2008) IFN-γ regulation of vacuolar pH, cathepsin
D processing and autophagy in mammary epithelial cells. Journal of cellular bioemistry,
105(1), 208–218.
[80] Pyo, J. O., Jang, M. H., Kwon, Y. K., Lee, H. J., Jun, J. I. L., Woo, H. N., Cho, D. H., Choi, B. Y.,
Lee, H., Kim, J. H., et al. (2005) Essential roles of Atg5 and FADD in autophagic cell death.
Journal of Biological Chemistry, 280(21), 20722–20729.
[81] Yu, L., McPhee, C. K., Zheng, L., Mardones, G. A., Rong, Y., Peng, J., Mi, N., Zhao, Y., Liu,
Z., Wan, F., et al. (2010) Termination of autophagy and reformation of lysosomes regulated
by mTOR. Nature, 465(7300), 942–946.
[82] Duran, A., Amanchy, R., Linares, J. F., Joshi, J., Abu-Baker, S., Porollo, A., Hansen, M.,
Moscat, J., and Diaz-Meco, M. T. (2011) p62 is a key regulator of nutrient sensing in the
mTORC1 pathway. Molecular cell, 44(1), 134–146.
[83] Hay, N. and Sonenberg, N. (2004) Upstream and downstream of mTOR. Genes & develop-
ment, 18(16), 1926–1945.
[84] Sabatini, D. M. (2006) mTOR and cancer: insights into a complex relationship. Nature Re-
views Cancer, 6(9), 729–734.
[85] Cantley, L. C. and Neel, B. G. (1999) New insights into tumor suppression: PTEN suppresses
tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proceedings
of the National Academy of Sciences, 96(8), 4240.
[86] Simpson, L. and Parsons, R. (2001) PTEN: life as a tumor suppressor. Experimental cell re-
sear, 264(1), 29–41.
References 69
[87] Cell Signaling Technology, Inc. Autophagy Signaling Diagram, accessed 2012–03–25. http:
//www.cellsignal.com.
[88] Nakatogawa, H., Suzuki, K., Kamada, Y., and Ohsumi, Y. (2009) Dynamics and diversity in
autophagy mechanisms: lessons from yeast. Nature Reviews Molecular Cell Biology, 10(7),
458–467.
[89] Itakura, E. and Mizushima, N. (2010) Characterization of autophagosome formation site by
a hierarchical analysis of mammalian Atg proteins.. Autophagy, 6(6), 764.
[90] Suzuki, K., Kubota, Y., Sekito, T., and Ohsumi, Y. (2007) Hierarchy of Atg proteins in pre-
autophagosomal structure organization. Genes to Cells, 12(2), 209–218.
[91] Fujita, N., Itoh, T., Omori, H., Fukuda, M., Noda, T., and Yoshimori, T. (2008) e Atg16L
complex speciৱes the site of LC3 lipidation for membrane biogenesis in autophagy.Molec-
ular biology of the cell, 19(5), 2092–2100.
[92] Weidberg, H., Shvets, E., Shpilka, T., Shimron, F., Shinder, V., and Elazar, Z. (2010) LC3 and
GATE-16/GABARAP subfamilies are both essential yet act diৰerently in autophagosome
biogenesis.e EMBO journal, 29(11), 1792–1802.
[93] Mizushima, N., Yoshimori, T., et al. (2007) How to interpret LC3 immunobloing. Au-
tophagy, 3(6), 542.
[94] Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba,
M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) Guidelines for the use and inter-
pretation of assays for monitoring autophagy in higher eukaryotes. Autophagy, 4(2), 151.
[95] Bjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H.,
and Johansen, T. (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and
has a protective eৰect on huntingtin-induced cell death.e Journal of cell biology, 171(4),
603–614.
[96] Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J. A., Outzen, H., Øvervatn, A.,
Bjørkøy, G., and Johansen, T. (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate
degradation of ubiquitinated protein aggregates by autophagy. Journal of Biological Chem-
istry, 282(33), 24131–24145.
[97] Chiang, H. L. and Dice, J. F. (1988) Peptide sequences that target proteins for enhanced
degradation during serum withdrawal.. Journal of Biological Chemistry, 263(14), 6797–6805.
[98] Chiang, H. L., Terlecky, S. R., Plant, C. P., Dice, J. F., et al. (1989) A role for a 70-kilodalton
heat shock protein in lysosomal degradation of intracellular proteins. Science, 246(4928),
382–385.
[99] Cuervo, A. M. (2010) Chaperone-mediated autophagy: selectivity pays oৰ. Trends in En-
docrinology & Metabolism, 21(3), 142–150.
70 References
[100] Kon, M., Ki৳n, R., Koga, H., Chapochnick, J., Macian, F., Varticovski, L., and Cuervo, A. M.
(2011) Chaperone-Mediated Autophagy Is Required for Tumor Growth. Science Transla-
tional Medicine, 3(109), 109ra117–109ra117.
[101] Ichimura, Y., Kumanomidou, T., Sou, Y., Mizushima, T., Ezaki, J., Ueno, T., Kominami, E.,
Yamane, T., Tanaka, K., and Komatsu, M. (2008) Structural basis for sorting mechanism of
p62 in selective autophagy. Journal of Biological Chemistry, 283(33), 22847–22857.
[102] Komatsu, M., Waguri, S., Koike, M., Sou, Y., Ueno, T., Hara, T., Mizushima, N., Iwata, J.,
Ezaki, J., Murata, S., et al. (2007) Homeostatic levels of p62 control cytoplasmic inclusion
body formation in autophagy-deৱcient mice. Cell, 131(6), 1149–1163.
[103] Zatloukal, K., Stumptner, C., Fuchsbichler, A., Heid, H., Schnoelzer, M., Kenner, L., Kleinert,
R., Prinz, M., Aguzzi, A., and Denk, H. (2002) p62 Is a common component of cytoplasmic
inclusions in protein aggregation diseases.e American journal of pathology, 160(1), 255.
[104] Vadlamudi, R. K., Joung, I., Strominger, J. L., and Shin, J. (1996) p62, a phosphotyrosine-
independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding
proteins. Journal of Biological Chemistry, 271(34), 20235.
[105] Kirkin, V., Lamark, T., Sou, Y., Bjørkøy, G., Nunn, J., Bruun, J., Shvets, E., McEwan, D.,
Clausen, T., Wild, P., et al. (2009) A role for NBR1 in autophagosomal degradation of ubiq-
uitinated substrates. Molecular cell, 33(4), 505–516.
[106] Cavey, J., Ralston, S., Hocking, L., Sheppard, P., Ciani, B., Searle, M., and Layৱeld, R. (2005)
Loss of Ubiquitin-Binding Associated With Paget’s Disease of Bone p62 (SQSTM1) Muta-
tions. Journal of Bone and Mineral Resear, 20(4), 619–624.
[107] Kim, P. K., Hailey, D. W., Mullen, R. T., and Lippinco-Schwartz, J. (2008) Ubiquitin signals
autophagic degradation of cytosolic proteins and peroxisomes. Proceedings of the National
Academy of Sciences, 105(52), 20567–20574.
[108] Takeyama, K., Aguiar, R. C. T., Gu, L., He, C., Freeman, G. J., Kutok, J. L., Aster, J. C., and
Shipp, M. A. (2003) e BAL-binding protein BBAP and related Deltex family members
exhibit ubiquitin-protein isopeptide ligase activity. Journal of Biological Chemistry, 278(24),
21930.
[109] Goenka, S., Cho, S. H., and Boothby, M. (2007) Collaborator of Stat6 (CoaSt6)-associated poly
(ADP-ribose) polymerase activity modulates Stat6-dependent gene transcription. Journal of
Biological Chemistry, 282(26), 18732.
[110] Yanagawa, T., Funasaka, T., Tsutsumi, S., Hu, H., Watanabe, H., and Raz, A. (2007) Regu-
lation of phosphoglucose isomerase/autocrine motility factor activities by the poly (ADP-
ribose) polymerase family-14. Cancer Resear, 67(18), 8682.
References 71
[111] Timinszky, G., Till, S., Hassa, P. O., Hothorn, M., Kustatscher, G., Nijmeijer, B., Colombelli,
J., Altmeyer, M., Stelzer, E. H. K., Scheৰzek, K., Hoiger, M. O., and Ladurner, A. G. (2009)
A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation.
Nature Structural & Molecular Biology, 16(9), 923–929.
[112] Fritsch, E. F., Sambrook, J., and Maniatis, T. (2001) Molecular Cloning, a Laboratory Manual,
Cold Spring Harbor Laboratory, 3rd edition.
[113] Kawamitsu, H., Hoshino, H., Okada, H., Miwa, M., Momoi, H., and Sugimura, T. (1984)
Monoclonal antibodies to poly (adenosine diphosphate ribose) recognize diৰerent struc-
tures. Bioemistry, 23(16), 3771–3777.
[114] Amini, R. M., Berglund, M., Rosenquist, R., Von Heideman, A., Lagercrantz, S., unberg,
U., Bergh, J., Sundström, C., Glimelius, B., and Enblad, G. (2002) A novel B-cell line (U-
2932) established from a patient with diৰuse large B-cell lymphoma following Hodgkin
lymphoma. Leukemia & lymphoma, 43(11), 2179–2189.
[115] Orvedahl, A., MacPherson, S., Sumpter Jr, R., Tallóczy, Z., Zou, Z., and Levine, B. (2010)
Autophagy protects against Sindbis virus infection of the central nervous system. Cell host
& microbe, 7(2), 115–127.
[116] Glaer, T., Wepf, A., Aebersold, R., and Gstaiger, M. (2009) An integrated work৲ow for
charting the human interaction proteome: insights into the PP2A system.Molecular Systems
Biology, 5(1).
[117] Candiano, G., Bruschi, M., Musante, L., Santucci, L., Ghiggeri, G. M., Carnemolla, B., Orec-
chia, P., Zardi, L., and Righei, P. G. (2004) Blue silver: A very sensitive colloidal Coomassie
G-250 staining for proteome analysis. Electrophoresis, 25(9), 1327–1333.
[118] Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model
to estimate the accuracy of peptide identiৱcations made by MS/MS and database search.
Analytical emistry, 74(20), 5383–5392.
[119] Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for
identifying proteins by tandem mass spectrometry. Analytical emistry, 75(17), 4646–4658.
[120] Morei, S., Armougom, F., Wallace, I. M., Higgins, D. G., Jongeneel, C. V., and Notredame,
C. (2007) e M-Coৰee web server: a meta-method for computing multiple sequence align-
ments by combining alternative alignment methods. Nucleic acids resear, 35(suppl 2),
W645–W648.
[121] Wallace, I. M., O’Sullivan, O., Higgins, D. G., and Notredame, C. (2006) M-Coৰee: com-
bining multiple sequence alignment methods with T-Coৰee. Nucleic acids resear, 34(6),
1692–1699.
72 References
[122] Notredame, C., Higgins, D. G., Heringa, J., et al. (2000) T-Coৰee: A novel method for fast
and accurate multiple sequence alignment. Journal of molecular biology, 302(1), 205–218.
[123] Kelley, L. A. and Sternberg, M. J. E. (2009) Protein structure prediction on the Web: a case
study using the Phyre server. Nature Protocols, 4(3), 363–371.
[124] Ezkurdia, I., Graña, O., Izarzugaza, J. M. G., and Tress, M. L. (2009) Assessment of domain
boundary predictions and the prediction of intramolecular contacts in CASP8. Proteins:
Structure, Function, and Bioinformatics, 77(S9), 196–209.
[125] Schrödinger, LLC (August, 2010) e PyMOL Molecular Graphics System, Version 1.3r1.
[126] Xu, J. and Zhang, Y. (2010) How signiৱcant is a protein structure similarity with TM-score=
0.5?. Bioinformatics, 26(7), 889.
[127] Amir-Zaltsman, Y., Ezra, E., Scherson, T., Zutra, A., Liauer, U. Z., and Salomon, Y. (1982)
ADP-ribosylation of microtubule proteins as catalyzed by cholera toxin..e EMBO journal,
1(2), 181.
[128] Leitinger, N. andWesierska-Gadek, J. (1993) ADP-ribosylation of nucleolar proteins in HeLa
tumor cells. Journal of cellular bioemistry, 52(2), 153–158.
[129] Lai, J. S. andHerr, W. (1992) Ethidium bromide provides a simple tool for identifying genuine
DNA-independent protein associations. Proceedings of the National Academy of Sciences,
89(15), 6958.
[130] Gao, G., Guo, X., and Goৰ, S. P. (2002) Inhibition of retroviral RNA production by ZAP, a
CCCH-type zinc ৱnger protein. Science, 297(5587), 1703–1706.
[131] Bick, M. J., Carroll, J. W. N., Gao, G., Goৰ, S. P., Rice, C. M., and MacDonald, M. R. (2003)
Expression of the zinc-ৱnger antiviral protein inhibits alphavirus replication. Journal of
virology, 77(21), 11555–11562.
[132] Sbodio, J. I., Lodish, H. F., and Chi, N. W. (2002) Tankyrase-2 oligomerizes with tankyrase-1
and binds to both TRF1 (telomere-repeat-binding factor 1) and IRAP (insulin-responsive
aminopeptidase).. Bioemical Journal, 361(Pt 3), 451.
[133] Schreiber, V., Amé, J. C., Dollé, P., Schultz, I., Rinaldi, B., Fraulob, V., Ménissier-de Murcia, J.,
and de Murcia, G. (2002) Poly (ADP-ribose) polymerase-2 (PARP-2) is required for e৳cient
base excision DNA repair in association with PARP-1 and XRCC1. Journal of Biological
Chemistry, 277(25), 23028–23036.
[134] Schwientek, M. S., Higgins, L. A., and Fallon, A. M. (2002) Cultured Aedes albopictus
mosquito cells accumulate elongation factor-1 [alpha](EF-1 [alpha]) during serum starva-
tion. Insect bioemistry and molecular biology, 32(9), 1055–1063.
References 73
[135] Lichtenstein, A., Minogue, P. J., Beyer, E. C., and Berthoud, V. M. (2011) Autophagy: a
pathway that contributes to connexin degradation. Journal of Cell Science, 124(6), 910–920.
[136] Moscat, J. and Diaz-Meco, M. T. (2009) p62 at the crossroads of autophagy, apoptosis, and
cancer. Cell, 137(6), 1001–1004.
[137] Paul, S., Kashyap, A. K., Jia, W., He, Y. W., and Schaefer, B. C. (2012) Selective Autophagy
of the Adaptor Protein Bcl10 Modulates T Cell Receptor Activation of NF-κB. Immunity,
doi:10.1016/j.immuni.2012.04.008.
[138] Kim, J. Y. and Ozato, K. (2009) e sequestosome 1/p62 aenuates cytokine gene expression
in activatedmacrophages by inhibiting IFN regulatory factor 8 and TNF receptor-associated
factor 6/NF-κB activity.e Journal of Immunology, 182(4), 2131–2140.
[139] Schroder, K., Hertzog, P. J., Ravasi, T., and Hume, D. A. (2004) Interferon-γ: an overview of
signals, mechanisms and functions. Journal of leukocyte biology, 75(2), 163–189.
[140] Kummar, S., Kinders, R., Gutierrez, M. E., Rubinstein, L., Parchment, R. E., Phillips, L. R., Ji,
J., Monks, A., Low, J. A., Chen, A., et al. (2009) Phase 0 clinical trial of the poly (ADP-ribose)
polymerase inhibitor ABT-888 in patients with advanced malignancies. Journal of Clinical
Oncology, 27(16), 2705.
[141] Bamford, S., Dawson, E., Forbes, S., Clements, J., Pee, R., Dogan, A., Flanagan, A., Teague,
J., Futreal, P. A., Straon, M. R., et al. (2004) e COSMIC (Catalogue of Somatic Mutations
in Cancer) database and website. British journal of cancer, 91(2), 355–358.
Curriculum Vitae
Name Hans Christian Winkler
Date of birth March 8, 1986
Place of birth Winterthur, ZH
Place of origin Zürich, ZH and Basel, BS
11/2011–5/2012 esis work under the supervision of Dr. Paul O. Hassa, Institute of
Veterinary Biochemistry and Molecular Biology, Vetsuisse Faculty, Uni-
versity of Zurich
8/2011–10/2011 Staatsexamen in Veterinary Medicine
8/2010–1/2011
3/2010–4/2010
Experimental work under the supervision of Dr. Paul O. Hassa, in the
context of the „Schwerpunktfach Biomedizinische Forschung”, Institute
of Veterinary Biochemistry and Molecular Biology, Vetsuisse Faculty,
University of Zurich
6/2009–8/2009 Leadership Program for Veterinary Students, Cornell University,
Ithaca, USA. Experimental work „Cellular host ranges and tropisms of
canine and equine in৲uenza viruses” conducted in the laboratory of Dr.
Colin Parrish, Baker Institute
2008–2009 Immunology teaing assistant (Tutor) for Prof. Dr. Mark Suter, Im-
munology, Vetsuisse Faculty, University of Zurich
2007–2010 Tenical assistant at the Zebraৱsh hatchery of Prof. Dr. Stephan
Neuhauss, Institute of Molecular Life Sciences, University of Zurich
2006–2011 Course of studies in Veterinary Medicine at the Vetsuisse Faculty, Uni-
versity of Zurich. Schwerpunktfach Biomedizinische Forschung
7/2006 Maturität Maturitätsarbeit „Coৰein – Eigenschaen und Wirkungen
einer psychotropen Substanz”. HPLC analysis and lab work conducted
at Novartis AG, Basel
2002–2006 Alte Kantonssule Aarau, Aargau Akzentfach Latein, Schwerpunkt-
fach Biologie und Chemie, Ergänzungsfach Philosophie
1998–2002 Bezirkssule Fri, Aargau
1993–1998 Primary sool, Oberhof, Aargau
Acknowledgments
First, I would like to express my sincere gratitude to Prof. Dr.med. vet. U. Hübscher for giving me
the opportunity to carry out this work at the Institute of Veterinary Biochemistry and Molecular
Biology.
Special thanks go to Prof. Dr.med. vet et phil. II M. O. Hoiger as Program Director and for
personal advice.
I would like to express my gratitude to Dr. P. O. Hassa for giving me the opportunity to work in
his laboratory and for his guidance during this project. ank you for your constant availability
when I had questions and for your great support and patience.
Many thanks go to Dr. C. Blenn for collaboration with tools, methodical inputs and many inter-
esting discussions.
A big thank goes to R. Camicia for teaching me various experimental techniques (and some Italian
words) and always having time to answer my questions.
Kudos to the Stucki lab for pull-down troubleshooting and daily heat block sharing, to Andrej for
PAR detection and Roberta for thought-provoking discussions.
I alsowould like to highly acknowledge all the other institutemembers for the friendly atmosphere
at the institute.
Above all I would like to thank my family, my dear and incomparable girlfriend Eleni and my
colleagues for the continuous support.
